rfhg_107030.1

Basic information about the TSS

---

TSS ID: rfhg_107030.1 Species: human Chr: chr8		Start: 60621579 End: 60621612 Strand: +
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AY034106:0 GeneID: 5862 HGNC/MGI_ID: HGNC:9763 UniProt_ID: Nearer transcript ids and distances: AL137321:-479

Gene_name: RAB2A, member RAS oncogene family Gene_symbol: RAB2A Gene_synonyms: Gene_source: HGNC:9763

TATA-Box annotation

---

Distance to TSS:	-57145
Nearest PromoterID:	NM_017780
Entrez ID:	55636
Nearest Unigene:	Hs.20395
Nearest Refseq:	NM_017780
Nearest Ensembl:	ENSG00000171316
Gene Name:	RAB2A, member RAS oncogene family
Gene Alias:	CRG|HH5|IS3|KAL5
Gene Type:	protein-coding
CpG%:	0.030303
GC%:	0.411765
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@RAB2A p2@RAB2A p3@RAB2A p4@RAB2A p5@RAB2A p7@RAB2A p8@RAB2A p10@RAB2A
Sample		p1@RAB2A	p2@RAB2A	p3@RAB2A	p4@RAB2A	p5@RAB2A	p7@RAB2A	p8@RAB2A	p10@RAB2A
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	22.40	5.06	8.18	7.60	6.43	0.19	0.39	0.58
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	19.22	4.65	7.28	7.69	6.07	0.20	0.20	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	22.38	4.24	6.94	9.26	5.98	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	18.50	4.37	5.82	10.19	4.16	0.00	0.21	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	21.37	2.70	7.20	11.47	5.40	0.22	0.45	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	18.22	3.49	6.98	10.66	2.91	0.00	0.00	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	23.75	4.58	11.11	8.93	6.75	0.00	0.00	0.44
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	23.74	6.06	6.78	7.27	7.75	0.00	0.00	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	23.08	3.85	8.98	7.27	5.56	0.21	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	20.29	1.16	4.64	6.96	6.38	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	17.38	0.00	5.66	4.85	3.23	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	17.89	1.63	4.47	6.50	3.25	0.00	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	31.92	12.73	8.54	1.61	0.16	0.48	0.48	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	26.91	16.09	7.37	1.50	0.15	0.60	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	29.42	16.91	7.46	2.20	0.66	0.44	0.22	0.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	26.41	13.08	4.28	1.76	0.00	1.01	0.25	0.25
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	22.06	17.91	5.46	1.31	0.00	0.00	0.44	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	23.20	13.08	3.37	1.27	0.00	0.00	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	19.73	11.73	2.67	0.53	0.00	0.53	0.53	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	30.69	11.73	8.12	1.96	0.00	1.35	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	29.54	14.97	7.22	1.74	0.40	0.40	0.27	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	25.89	22.27	7.60	1.73	0.17	1.04	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	25.98	19.65	6.98	2.33	0.00	0.13	0.65	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	27.91	15.29	5.58	2.18	0.00	0.49	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	24.25	18.58	7.74	2.84	0.77	0.77	1.03	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	26.59	17.09	6.65	2.22	0.32	1.27	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	29.67	14.29	4.40	2.75	0.00	0.55	1.65	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	23.58	18.62	10.37	1.65	0.00	1.18	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	27.78	16.15	7.11	1.62	0.16	0.48	0.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	29.32	15.38	7.24	2.17	0.18	0.18	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	23.87	15.07	6.28	0.84	0.42	0.21	0.21	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	31.46	13.29	5.67	1.76	0.20	0.39	0.39	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	24.06	12.45	6.12	3.38	0.21	0.84	0.63	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	32.00	27.87	5.94	2.64	0.33	0.99	0.33	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	27.49	15.89	8.60	2.43	0.19	0.56	0.56	0.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	31.62	13.22	7.28	2.49	0.38	0.77	0.38	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	31.27	19.21	7.77	2.25	0.00	1.02	0.41	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	29.22	16.32	6.65	2.42	0.60	0.20	0.40	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	29.98	17.02	7.83	3.51	0.54	0.81	1.35	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	34.33	15.12	8.64	2.64	0.96	0.24	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	30.11	19.76	9.88	1.65	0.47	0.71	0.24	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	33.52	19.76	7.03	2.78	0.44	0.44	0.44	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	35.64	11.39	9.91	3.37	0.84	0.42	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	27.97	13.81	8.22	3.85	1.05	0.35	0.70	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	34.13	17.27	8.23	2.61	0.60	1.00	1.81	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	30.94	15.12	7.68	3.72	0.70	0.47	0.70	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	39.58	13.19	10.32	1.68	0.24	0.72	0.96	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	33.38	19.67	8.64	3.87	0.30	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	35.43	13.64	11.97	4.79	0.72	0.24	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	28.71	13.55	9.50	3.03	0.81	0.61	0.61	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	33.61	17.01	7.99	3.07	0.41	1.02	0.61	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	44.70	19.35	9.12	4.45	0.67	2.67	1.33	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	69.96	181.90	27.98	0.00	0.00	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	31.23	15.97	9.23	4.61	0.71	0.71	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	31.48	14.91	11.27	1.99	0.66	0.66	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	58.73	93.12	18.46	1.68	0.00	3.36	0.84	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	42.25	34.90	10.56	1.84	0.46	1.84	0.92	1.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	36.30	14.58	11.34	1.62	1.30	0.97	0.97	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	32.12	15.42	7.07	1.61	0.32	1.28	1.93	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	49.98	37.72	11.00	2.51	1.57	1.57	0.63	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	31.73	17.63	8.46	1.41	0.00	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	33.09	17.95	14.02	3.93	0.56	1.12	0.56	0.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	41.40	47.77	9.55	0.80	0.80	2.39	6.37	5.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	50.97	16.65	12.23	4.08	1.36	3.74	0.68	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	38.02	14.30	6.50	4.22	0.65	0.32	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	34.08	7.81	10.65	5.68	0.35	1.06	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	145.48	129.31	32.33	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	150.05	189.54	15.79	0.00	0.00	7.90	7.90	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	47.29	14.14	10.73	4.88	0.49	0.98	1.46	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	46.12	22.31	14.38	3.47	0.00	0.00	0.00	1.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	39.41	16.42	15.95	4.22	0.00	1.41	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	44.38	29.81	12.59	2.65	0.66	0.66	0.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	43.93	23.51	10.52	2.17	0.31	0.93	0.31	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	39.44	19.26	12.84	3.67	0.00	0.31	0.92	0.00
Adipocyte - breast, donor1	11376-118A8	124.17	46.09	25.50	24.07	4.12	1.58	0.95	0.16
Adipocyte - breast, donor2	11327-117E4	118.39	44.92	22.14	36.26	7.06	2.73	1.12	0.48
Adipocyte - omental, donor1	11473-119C6	163.61	62.72	25.70	37.66	8.14	0.89	0.64	0.64
Adipocyte - omental, donor2	11474-119C7	109.88	33.64	13.45	35.88	7.47	3.74	1.49	3.74
Adipocyte - omental, donor3	11475-119C8	85.74	37.85	16.08	28.80	5.69	0.33	0.67	0.67
Adipocyte - perirenal, donor1	11476-119C9	103.99	33.81	16.59	18.50	4.47	3.19	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	54.98	12.09	9.90	4.40	1.10	0.00	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	34.78	35.23	13.10	4.97	0.00	0.45	0.45	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	40.49	27.11	14.08	6.95	0.87	0.17	0.17	0.17
Adipocyte differentiation, day04, donor1	13019-139D4	105.22	53.00	33.05	9.78	0.98	0.20	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	69.49	24.45	11.84	5.66	1.29	0.51	0.26	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	54.36	22.86	19.79	8.36	0.84	0.56	0.56	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	52.90	27.63	24.69	4.11	2.35	0.00	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	120.49	46.65	30.97	26.62	2.65	0.16	0.08	0.08
Adipocyte differentiation, day08, donor2	13023-139D8	67.13	20.01	15.81	9.04	0.97	0.00	0.65	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	51.72	17.06	17.06	11.20	1.60	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	60.65	19.48	12.24	7.23	2.23	0.56	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	73.61	29.94	21.63	11.64	2.91	0.42	0.42	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	60.28	22.60	11.80	8.29	1.76	0.00	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	56.94	20.94	11.78	10.14	1.96	0.65	0.33	0.33
Adipocyte differentiation, day12, donor4	13030-139E6	54.80	15.83	13.40	12.79	1.83	0.00	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	64.31	5.52	18.56	9.06	1.33	0.22	0.00	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	21.16	0.00	6.81	1.43	0.72	0.00	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	25.16	2.40	11.98	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	66.57	14.03	20.33	5.94	1.08	0.36	0.00	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	36.82	16.73	11.71	5.02	5.02	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	53.83	11.30	17.26	4.73	1.23	0.21	0.00	0.41
Anulus Pulposus Cell, donor1	11248-116E6	65.22	57.67	17.96	3.89	0.34	0.34	0.11	0.11
Anulus Pulposus Cell, donor2	11463-119B5	50.70	32.82	14.69	2.69	0.73	0.49	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	50.77	22.91	15.73	6.74	0.45	0.90	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	53.83	25.61	15.19	9.12	0.43	0.87	0.43	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	53.51	25.68	10.70	2.14	2.14	4.28	2.14	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	60.68	27.20	14.35	5.38	1.20	0.30	0.00	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	70.82	34.15	10.12	6.32	2.53	1.26	1.26	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	55.45	19.14	7.92	4.62	1.32	0.66	1.32	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	57.18	25.34	15.59	7.80	0.97	1.30	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	64.08	25.73	14.56	9.22	1.46	0.49	0.97	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	58.20	24.94	7.72	4.75	2.97	0.00	1.78	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	51.98	35.03	13.18	6.40	1.51	0.38	0.75	1.51
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	58.78	29.03	15.96	10.16	1.45	1.45	0.00	1.45
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	46.39	21.31	10.03	3.76	1.25	2.51	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	75.45	40.20	18.29	7.91	1.98	0.00	0.16	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	46.40	20.47	13.65	9.55	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	66.80	28.35	15.23	10.10	2.11	0.45	0.60	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	60.54	21.97	14.47	8.57	2.68	0.00	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	64.05	25.32	11.15	7.75	0.57	0.19	0.00	0.76
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	65.22	24.59	11.76	7.75	2.41	0.27	0.00	0.53
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	50.72	24.39	12.68	6.83	0.98	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	67.01	23.88	12.44	6.80	1.49	0.33	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	38.42	14.41	8.41	10.81	0.00	0.00	0.00	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	46.02	38.94	10.62	7.08	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	61.41	24.87	12.01	7.55	1.20	0.00	0.51	0.17
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	71.31	29.36	16.78	0.00	0.00	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	71.84	27.18	17.96	9.22	2.91	0.49	0.97	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	64.13	33.39	18.59	6.45	1.14	0.00	0.38	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	44.82	26.65	12.11	3.63	0.00	2.42	2.42	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	72.96	24.51	22.23	6.84	2.28	0.00	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	63.06	24.16	13.90	8.76	2.14	0.64	0.00	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	51.88	18.07	7.23	6.97	0.77	0.52	0.26	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	58.65	22.52	15.01	5.16	1.41	1.88	0.00	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	66.24	18.33	10.29	7.72	1.61	0.32	0.64	1.29
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	57.08	25.68	5.71	3.57	2.14	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	47.38	21.64	9.94	3.51	1.17	0.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	69.85	25.89	13.25	7.23	1.20	0.30	1.51	0.30
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	67.72	20.20	10.69	2.38	0.00	0.00	0.00	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	63.57	30.51	10.68	6.61	0.51	1.02	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	66.22	31.07	15.28	7.39	0.76	0.00	0.76	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	50.83	18.43	7.62	6.35	3.18	0.64	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	56.96	20.28	15.97	8.20	2.16	0.43	0.00	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	64.56	28.37	11.22	8.47	1.69	0.21	0.42	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	53.94	18.27	8.12	6.67	1.16	0.29	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	49.13	17.01	14.17	7.56	1.89	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	66.96	22.38	14.58	7.46	1.53	0.68	0.51	0.34
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	46.33	13.90	6.95	2.32	2.32	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	80.28	38.03	14.79	8.45	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	64.11	21.23	11.79	10.29	1.50	0.64	0.86	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	55.35	17.45	10.23	9.02	0.60	0.00	0.60	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	66.34	25.51	16.04	3.64	0.73	0.00	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	59.77	28.05	13.79	7.59	1.38	0.46	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	45.91	20.40	2.55	0.00	0.00	5.10	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	72.46	31.27	17.03	12.20	1.78	0.76	0.25	1.02
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	71.22	28.28	13.21	10.32	1.65	0.62	0.41	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	52.33	24.17	8.87	6.73	1.84	0.31	0.61	0.31
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	69.79	32.50	18.16	13.86	0.48	0.96	0.48	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	65.86	25.94	13.75	9.98	2.22	1.11	0.22	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	64.08	24.41	12.21	4.58	0.00	0.00	3.05	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	62.59	21.60	15.51	15.51	1.66	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	68.32	24.36	14.83	8.74	1.32	0.26	1.06	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	58.52	15.63	9.09	6.18	2.18	0.73	0.73	0.36
Astrocyte - cerebellum, donor1	11500-119F6	45.56	9.70	14.98	5.53	1.11	0.00	0.00	0.12
Astrocyte - cerebellum, donor2	11580-120F5	37.48	3.59	8.73	3.94	0.68	0.00	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	27.27	3.36	6.08	1.26	0.21	0.21	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	60.65	23.01	16.03	2.79	0.70	0.70	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	54.52	13.91	12.29	3.40	0.81	0.32	0.49	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	73.24	14.02	17.60	5.07	1.79	0.15	0.15	0.30
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	48.63	16.51	11.24	2.52	2.29	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	49.99	18.04	14.53	3.51	1.63	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	46.32	20.14	10.81	3.87	1.14	0.00	0.00	0.00
Basophils, donor1	12241-129G9	124.49	5.23	14.91	22.75	12.29	0.26	0.26	0.00
Basophils, donor2	12242-129H1	129.89	19.84	15.15	30.67	40.05	0.00	0.00	0.36
Basophils, donor3	12243-129H2	123.77	7.79	23.23	22.34	10.00	0.15	0.29	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	37.08	7.76	10.78	3.88	0.22	0.43	0.00	0.00
Bronchial Epithelial Cell, donor2	11591-120G7	17.37	0.46	4.57	0.91	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	14.35	7.17	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	30.75	13.18	8.16	5.02	0.00	0.00	0.63	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	31.82	3.33	11.44	2.91	0.42	0.00	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	37.31	5.76	8.29	2.30	0.69	0.23	0.00	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	42.83	21.59	13.32	2.16	0.90	0.00	0.54	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	36.28	5.98	10.82	10.41	3.71	0.10	0.10	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	68.24	10.25	20.50	11.41	3.73	0.23	0.70	0.23
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	76.75	17.27	14.71	10.23	3.20	0.00	0.00	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	113.76	10.34	20.68	20.68	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	97.50	9.58	22.54	25.36	10.14	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	88.16	8.54	13.36	18.75	10.76	0.00	0.56	0.00
CD14+ Monocytes, donor3	11381-118B4	93.74	9.88	17.78	16.25	12.29	0.00	0.00	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	93.97	16.13	25.47	4.25	1.98	0.57	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	99.32	22.74	26.91	7.58	1.90	0.38	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	138.07	12.82	28.60	8.22	0.99	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	85.28	6.94	15.61	15.61	3.18	0.29	0.14	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	75.13	5.73	9.96	17.50	3.32	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	104.47	7.34	16.11	18.24	6.40	0.47	0.24	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	63.44	3.52	8.70	12.05	2.85	0.50	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	70.11	4.69	10.21	15.46	5.24	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	72.40	8.93	13.64	20.58	6.20	0.00	0.50	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	58.94	4.50	8.81	11.94	2.74	0.20	0.00	0.39
CD14+ monocytes - treated with BCG, donor2	11870-125B7	68.01	3.38	9.79	14.78	2.67	0.00	0.00	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	87.27	8.71	16.98	22.63	7.18	0.65	0.22	0.22
CD14+ monocytes - treated with Candida, donor1	11868-125B5	67.66	3.51	11.94	9.13	3.28	0.47	0.23	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	84.48	2.64	14.78	23.23	4.75	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	85.42	5.55	13.31	16.64	7.77	1.11	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	69.32	6.40	11.45	13.39	2.23	0.15	0.15	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	65.45	6.19	7.98	9.78	4.99	0.40	0.20	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	87.86	10.41	17.07	20.61	6.25	0.00	0.42	0.62
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	63.83	4.80	10.07	11.44	4.12	0.23	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	68.09	3.85	14.48	15.83	6.56	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	68.52	4.36	11.35	15.28	4.80	0.00	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	77.20	7.53	11.30	16.68	4.84	0.00	0.27	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	100.84	5.41	14.48	23.55	5.23	0.17	1.05	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	109.41	9.26	15.57	24.41	9.26	0.00	0.42	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	51.99	5.33	11.94	10.47	2.57	0.00	0.37	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	62.70	7.05	13.03	10.92	3.17	0.00	0.35	0.70
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	70.63	8.34	8.34	13.16	2.19	0.00	0.00	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	64.52	4.53	10.99	12.38	1.39	0.17	0.00	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	62.81	3.35	12.27	14.12	5.20	0.00	0.00	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	96.78	9.05	20.05	26.94	4.31	0.22	0.22	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	50.37	8.19	13.10	11.06	2.46	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	63.28	6.03	12.75	12.98	3.48	0.23	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	77.25	10.21	12.76	16.94	4.41	0.00	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	80.86	10.90	14.60	8.50	2.18	0.22	0.22	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	87.78	13.17	15.94	12.70	5.08	0.23	0.46	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	89.68	14.73	15.60	9.10	1.52	0.00	0.00	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	106.98	13.55	22.74	10.12	2.96	0.16	0.00	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	91.69	12.75	20.43	9.78	2.62	0.35	0.00	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	124.86	18.28	26.31	10.26	2.45	0.45	0.00	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	114.57	11.74	17.61	17.10	1.79	0.26	0.77	0.51
CD14-CD16+ Monocytes, donor2	11800-124C9	113.30	10.54	15.81	15.59	2.85	0.22	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	110.54	12.42	17.69	13.90	2.74	0.21	0.21	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	75.20	20.32	24.39	8.13	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	103.05	10.85	16.27	6.10	2.03	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	96.31	11.39	14.50	12.43	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	108.74	18.12	17.06	7.46	0.53	0.00	0.00	1.60
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	99.17	16.08	16.62	6.43	1.07	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	103.18	11.23	12.63	4.91	2.11	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	105.89	9.41	18.82	3.92	0.78	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	94.92	17.14	11.86	3.95	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	106.03	9.04	18.08	9.04	2.47	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	87.05	13.06	14.51	15.23	5.08	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	82.79	8.58	11.61	14.14	2.52	0.00	1.51	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	33.94	11.31	17.78	2.42	1.21	0.00	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	23.97	7.19	12.38	2.40	0.40	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	75.30	6.02	11.04	12.05	5.02	0.00	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	124.16	11.80	10.67	26.40	26.40	0.00	0.00	0.56
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	65.76	13.53	14.65	7.52	4.51	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	68.55	18.94	17.59	6.76	2.93	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	126.40	18.21	13.93	28.56	15.35	0.71	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	117.57	17.15	9.80	22.05	19.60	0.00	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	120.78	11.28	8.23	18.60	8.54	0.30	0.30	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	61.00	8.68	14.55	4.34	2.55	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	71.87	7.64	10.78	7.64	1.12	0.00	0.22	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	67.27	6.32	9.49	6.04	1.44	0.29	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	116.15	17.54	13.27	10.43	3.32	0.00	0.47	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	110.97	16.15	23.18	8.43	3.51	0.00	0.70	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	95.59	23.07	6.59	6.59	6.59	0.00	3.30	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	47.69	7.08	10.41	3.90	1.73	0.14	0.14	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	50.16	8.64	9.49	4.24	1.53	0.00	0.17	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	47.07	5.96	9.03	3.22	0.97	0.32	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	103.11	10.76	11.66	16.14	4.93	0.90	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	112.15	17.47	9.08	9.08	4.19	0.00	0.00	0.70
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	93.72	8.80	11.00	11.44	5.72	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	47.22	11.81	9.28	2.11	3.79	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	42.18	6.03	9.56	2.70	1.66	0.21	0.21	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	37.76	6.35	8.02	5.01	1.34	1.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	81.31	17.13	14.41	7.61	4.35	0.00	0.27	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	109.33	23.05	11.79	7.50	4.29	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	82.49	25.11	12.55	12.55	1.79	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	56.00	10.57	15.02	7.60	4.08	0.00	0.19	0.19
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	60.87	7.80	9.96	5.85	1.30	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	60.94	6.09	10.72	5.25	2.73	0.21	0.42	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	96.06	18.20	14.16	11.63	6.57	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	90.98	14.30	14.30	12.56	5.20	0.00	0.00	0.43
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	98.06	13.51	10.02	8.72	3.49	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	118.77	19.79	19.30	7.92	1.98	0.49	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	91.40	14.77	14.77	9.23	3.69	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	93.52	9.77	18.15	11.17	5.58	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	122.68	16.06	19.11	5.54	5.26	0.55	0.00	0.55
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	122.45	20.86	19.63	10.55	6.13	0.00	0.25	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	113.96	20.02	7.70	9.24	6.16	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	121.40	15.40	18.62	8.24	3.94	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	141.27	18.00	24.93	8.31	5.54	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	115.57	14.41	11.13	37.65	37.65	0.98	0.00	0.00
CD8+ T Cells, donor2	11307-117C2	123.52	15.77	9.01	34.54	40.17	0.75	0.75	0.38
CD8+ T Cells, donor3	11383-118B6	126.50	11.87	9.34	30.30	25.75	0.50	1.01	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	22.02	9.18	3.67	1.84	0.46	0.23	0.00	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	21.57	12.94	3.83	2.64	0.48	0.00	0.24	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	23.26	12.86	3.01	2.74	0.82	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	25.82	18.31	3.00	3.30	1.20	0.60	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	25.44	10.32	4.32	2.88	1.44	0.00	0.24	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	21.15	10.69	4.55	6.14	2.05	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	22.81	6.95	4.78	5.21	1.30	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	23.16	8.16	2.90	4.74	1.32	0.00	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	28.14	6.80	3.99	5.16	0.70	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	23.24	11.47	4.23	3.62	1.81	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	21.50	8.72	3.78	4.94	1.74	0.00	0.29	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	22.11	10.39	4.00	4.80	0.53	0.00	0.00	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	28.02	3.94	2.19	16.63	4.38	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	25.96	3.19	2.73	12.30	2.73	0.00	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	27.60	4.48	3.73	17.90	2.98	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	24.49	6.84	6.12	5.40	1.08	0.36	0.36	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	23.59	7.48	4.60	5.47	0.29	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	23.57	8.01	4.24	5.19	0.94	0.00	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	28.84	11.73	3.49	4.75	0.63	0.00	0.00	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	24.91	8.61	4.61	6.46	0.92	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	24.04	8.01	5.45	3.53	1.28	0.32	0.00	0.32
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	24.48	8.41	4.21	6.12	1.53	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	19.71	6.31	3.55	2.76	2.36	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	27.99	12.10	3.03	4.54	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	24.89	4.01	4.01	18.47	1.61	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	25.88	4.90	2.10	24.48	2.10	0.00	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	34.06	6.01	7.01	15.03	2.00	1.00	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	80.42	14.62	3.66	3.66	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	61.27	17.79	9.88	4.94	2.96	0.00	0.99	0.49
Cardiac Myocyte, donor3	11686-122I3	83.98	28.52	16.31	7.16	0.32	0.11	0.00	0.21
Chondrocyte - de diff, donor1	11261-116G1	82.51	37.44	22.19	8.67	2.43	0.69	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	47.98	33.41	10.66	5.33	1.42	0.71	0.36	0.36
Chondrocyte - de diff, donor3	11410-118E6	62.81	42.78	16.73	4.10	0.91	1.25	0.11	0.34
Chondrocyte - re diff, donor2	11339-117F7	136.08	82.36	18.80	11.64	1.79	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	89.78	38.01	19.41	6.87	1.62	1.21	0.40	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	75.51	23.64	16.41	5.62	2.75	0.11	0.46	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	57.50	17.10	14.96	5.13	1.07	0.43	1.07	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	67.17	21.06	16.99	6.37	0.97	0.53	0.35	0.00
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	112.24	30.08	29.25	7.06	0.92	0.09	0.18	0.18
Corneal Epithelial Cells, donor1	11526-119I5	31.40	2.42	9.22	1.98	0.22	0.00	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	21.61	7.96	9.10	1.14	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	34.51	5.88	11.25	2.30	0.77	0.26	0.77	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	69.84	9.25	19.65	5.94	0.66	0.17	0.17	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	69.07	15.14	22.71	6.94	0.32	0.32	0.95	0.63
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	41.41	3.45	13.80	3.45	3.45	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	47.08	11.23	11.66	4.86	0.97	0.11	0.11	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	60.13	16.40	17.77	10.25	6.49	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	73.77	15.67	20.24	9.79	5.88	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	69.69	14.03	18.87	13.07	13.07	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	63.21	6.34	11.01	5.34	1.00	0.00	0.00	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	43.42	7.63	4.11	6.45	1.17	0.00	0.00	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	77.49	9.05	9.62	8.77	0.85	0.00	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	56.62	7.47	6.29	5.90	1.97	0.00	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	43.34	4.07	7.56	7.56	2.04	0.00	0.29	0.00
Endothelial Cells - Artery, donor2	11341-117F9	71.05	10.12	8.94	6.59	1.18	0.00	0.24	0.24
Endothelial Cells - Artery, donor3	11413-118E9	65.57	5.61	7.89	6.84	1.75	0.00	0.00	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	85.34	13.08	12.41	6.21	1.33	0.22	0.22	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	111.67	15.52	12.47	9.13	0.61	0.30	0.00	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	90.77	15.50	10.15	13.53	1.41	0.28	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	59.13	5.35	8.32	9.81	0.89	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	48.42	8.33	4.17	6.77	0.52	0.00	0.00	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	43.39	4.40	6.95	3.97	1.28	0.14	0.00	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	85.63	10.00	13.60	15.20	2.40	0.00	0.00	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	45.60	4.19	6.29	3.67	1.57	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	104.74	18.76	17.02	7.83	2.11	0.12	0.25	0.25
Endothelial Cells - Umbilical vein, donor2	11324-117E1	76.69	10.43	9.78	5.43	2.39	0.00	0.00	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	97.70	10.01	14.29	8.18	1.22	0.00	0.12	0.24
Endothelial Cells - Vein, donor1	11267-116G7	64.84	1.14	9.10	5.69	1.14	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	55.18	2.79	10.48	6.99	1.40	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	66.26	6.75	9.89	6.44	2.04	0.63	0.00	0.47
Eosinophils, donor1	12244-129H3	76.23	30.49	15.25	15.25	30.49	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	570.99	13.20	80.86	90.76	37.96	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	324.58	10.70	78.47	53.50	21.40	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	30.30	2.93	10.75	2.69	0.49	0.00	0.00	0.24
Esophageal Epithelial Cells, donor2	11587-120G3	31.20	2.08	2.08	2.08	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	0.00	0.00	16.27	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	105.09	51.72	25.04	16.42	3.28	1.23	2.05	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	38.65	20.91	6.24	6.90	1.42	0.55	0.44	0.99
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	50.05	34.56	8.67	5.96	0.98	1.84	0.76	0.65
Fibroblast - Aortic Adventitial, donor1	11245-116E3	89.26	36.63	18.31	11.40	1.94	0.36	0.24	0.36
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	78.88	28.93	20.20	12.56	1.77	0.27	0.14	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	64.34	28.27	15.61	7.70	1.16	0.53	0.32	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	61.66	24.50	11.59	6.32	0.79	0.26	0.00	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	73.08	37.21	17.94	7.31	0.66	0.66	0.00	0.33
Fibroblast - Cardiac, donor1	11268-116G8	61.24	26.76	11.34	5.90	0.91	0.00	0.45	0.00
Fibroblast - Cardiac, donor2	11345-117G4	62.15	12.89	19.71	9.85	3.03	0.00	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	54.10	16.56	12.30	5.99	1.42	0.00	0.00	0.32
Fibroblast - Cardiac, donor4	11452-119A3	87.60	47.89	24.85	8.18	1.82	0.00	0.00	0.00
Fibroblast - Cardiac, donor5	11456-119A7	70.56	14.97	11.68	6.85	1.40	0.51	0.25	0.13
Fibroblast - Cardiac, donor6	11460-119B2	69.58	19.71	12.28	9.40	3.64	0.15	0.15	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	59.22	20.23	17.15	8.04	2.41	0.13	0.00	0.13
Fibroblast - Choroid Plexus, donor2	11572-120E6	58.67	22.87	18.12	9.49	2.16	1.29	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	105.47	5.86	19.04	4.39	0.00	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	45.67	5.07	11.76	2.31	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	69.88	85.48	20.35	5.43	0.68	0.00	0.00	0.17
Fibroblast - Dermal, donor1	11269-116G9	61.04	28.64	11.74	2.58	1.41	0.94	0.47	0.00
Fibroblast - Dermal, donor2	11346-117G5	50.00	23.58	12.26	3.30	0.94	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	58.03	39.89	13.42	3.63	0.48	0.12	0.00	0.48
Fibroblast - Dermal, donor4	11450-119A1	61.84	24.19	15.94	6.90	0.79	0.23	0.11	0.11
Fibroblast - Dermal, donor5	11454-119A5	69.43	24.25	17.27	8.20	0.87	0.52	0.17	0.00
Fibroblast - Dermal, donor6	11458-119A9	82.67	30.37	18.03	7.31	1.95	0.16	0.16	0.16
Fibroblast - Gingival, donor1	11237-116D4	68.72	55.18	26.86	4.79	1.04	0.00	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	107.16	47.42	20.70	10.22	1.31	0.26	0.79	0.52
Fibroblast - Gingival, donor2	11318-117D4	78.15	33.74	18.32	5.67	1.05	0.13	0.13	0.13
Fibroblast - Gingival, donor3	11394-118C8	65.36	47.28	22.72	4.64	1.35	0.00	0.10	0.00
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	75.84	44.67	17.66	7.27	2.08	2.08	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	69.95	27.49	16.92	4.93	1.23	0.35	0.35	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	104.61	43.81	28.37	12.78	1.40	0.16	0.16	0.78
Fibroblast - Gingival, donor6 (control)	11922-125H5	72.62	46.52	19.74	8.11	1.62	0.54	0.27	0.41
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	40.93	12.70	10.59	3.88	0.35	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	91.40	44.02	20.33	11.26	2.49	1.02	0.29	1.02
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	104.45	47.86	18.41	11.73	1.64	0.27	0.68	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	110.24	33.79	25.45	12.29	2.96	0.33	0.22	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	101.54	51.51	23.77	11.01	1.76	0.88	0.59	1.32
Fibroblast - Lung, donor1	11270-116H1	29.91	2.72	8.16	2.72	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	65.65	46.26	13.43	4.48	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	59.72	15.62	13.93	5.70	1.06	0.00	0.84	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	72.47	15.83	23.32	5.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	43.36	20.98	13.99	8.39	0.00	0.00	0.00	1.40
Fibroblast - Lymphatic, donor3	11667-122G2	26.31	3.92	7.00	1.12	0.28	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	103.93	24.76	32.48	11.37	2.03	0.00	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	39.94	0.00	19.97	7.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	65.52	11.91	53.61	5.96	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	89.03	34.33	25.80	7.37	1.55	0.39	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	102.08	27.00	23.66	4.70	1.21	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	112.30	54.47	26.31	7.65	1.84	0.00	0.31	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	69.46	30.53	15.65	9.16	1.91	0.38	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	100.98	41.04	17.82	17.01	1.62	1.08	0.81	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	78.98	25.75	18.56	4.87	1.16	0.23	0.23	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	92.85	27.74	20.56	11.61	2.65	0.22	0.44	0.55
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	68.27	13.00	18.90	7.72	2.03	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	52.79	6.01	16.71	2.67	0.00	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	66.42	33.61	11.47	5.93	0.79	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	87.52	24.41	17.26	13.69	3.37	0.40	0.20	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	77.26	63.59	22.20	9.77	0.71	0.89	0.18	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	81.20	64.45	18.92	8.28	0.99	0.20	0.20	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	67.09	17.45	9.93	9.33	0.30	0.60	0.30	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	108.28	60.99	25.15	10.26	2.05	0.43	0.00	0.00
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	92.63	29.36	15.69	14.43	1.52	0.51	0.00	0.25
Fibroblast - skin normal, donor1	11553-120C5	99.60	57.76	20.84	10.50	0.98	0.16	0.82	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	86.62	27.27	21.45	8.22	1.80	0.20	0.40	0.20
Fibroblast - skin normal, donor2	11561-120D4	115.43	53.04	22.10	10.45	2.31	0.40	0.30	0.20
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	95.20	33.55	17.23	9.97	0.91	0.30	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	99.00	61.97	23.86	8.78	1.74	0.50	0.25	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	82.91	78.98	24.96	8.21	0.85	0.00	0.17	0.17
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	68.97	19.05	11.17	6.24	2.96	0.33	0.33	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	113.77	42.82	27.06	13.53	1.70	0.32	0.32	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	76.92	33.74	19.23	7.93	1.69	0.17	0.17	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	83.90	93.62	13.33	7.68	0.78	1.10	0.16	1.57
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	332.40	775.59	88.64	88.64	22.16	0.00	22.16	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	70.59	59.26	10.46	13.94	3.49	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	92.92	15.95	18.55	18.20	3.47	0.35	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	88.74	18.22	20.82	12.23	2.60	0.78	0.00	0.26
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	86.11	16.61	20.44	13.54	3.07	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	48.23	5.36	8.42	5.36	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	43.39	4.47	12.12	5.10	3.19	0.64	0.00	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	70.46	10.27	22.25	6.56	2.28	0.86	0.00	0.29
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	55.98	4.41	14.06	3.03	1.10	1.10	0.28	0.28
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	44.98	5.25	13.70	5.25	0.91	0.68	1.14	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	56.07	4.56	18.82	3.17	2.38	0.79	0.59	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	45.99	3.44	14.54	2.38	0.26	1.06	1.06	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	55.77	7.50	10.44	5.54	0.65	0.33	0.98	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	48.20	8.84	11.94	2.65	2.65	0.44	0.00	1.33
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	59.78	7.63	15.55	6.36	2.26	0.28	0.14	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	67.11	6.77	23.27	7.39	1.85	0.00	0.37	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	52.92	6.98	13.97	5.37	2.95	0.54	0.27	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	68.27	4.34	21.43	7.68	2.60	0.37	0.12	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	72.12	3.60	21.73	5.26	3.60	0.14	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	55.30	5.69	9.56	5.08	1.83	0.41	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	63.66	5.48	12.55	5.48	3.19	0.23	0.00	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	77.60	3.99	20.55	7.22	1.74	0.37	0.12	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	65.14	5.68	20.98	6.99	1.53	0.22	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	71.51	11.23	14.48	12.41	2.36	0.30	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	69.94	7.15	21.94	7.63	3.66	0.48	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	58.31	5.59	15.42	7.37	1.79	0.00	0.00	0.67
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	64.52	5.65	11.49	10.28	4.03	0.20	0.60	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	81.43	10.52	18.49	8.48	3.56	0.85	0.34	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	77.23	11.97	17.29	13.57	4.26	0.00	0.27	0.18
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	75.13	11.13	14.57	9.57	3.02	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	65.92	9.39	15.88	11.27	3.42	0.00	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	81.55	10.84	19.59	11.40	4.43	0.11	0.44	0.11
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	74.13	11.56	18.39	12.15	4.16	0.17	0.00	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	67.38	10.62	16.13	13.07	4.08	0.00	0.00	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	72.62	11.97	14.65	11.76	3.30	0.83	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	77.48	6.34	18.22	8.42	3.11	0.69	0.46	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	67.37	8.00	13.17	6.84	4.00	0.33	0.33	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	69.22	9.04	13.23	12.12	3.75	0.00	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	92.86	13.41	18.69	12.42	4.43	0.74	0.37	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	62.57	9.40	14.10	9.40	3.24	0.16	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	82.10	9.62	16.68	7.06	2.25	0.32	0.32	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	81.11	8.53	19.42	9.66	3.70	0.19	0.38	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	61.21	8.70	13.29	7.59	4.11	0.16	0.32	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	78.76	12.77	11.86	8.51	3.65	0.91	0.00	0.30
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	79.87	11.60	18.82	11.08	5.54	0.42	0.42	0.21
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	74.21	10.10	11.64	7.68	2.20	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	79.11	8.42	15.15	10.94	3.09	0.00	0.56	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	95.73	13.24	20.92	14.72	5.46	0.00	1.11	0.09
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	65.25	11.50	10.96	10.96	4.81	0.00	0.53	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	94.10	15.30	16.37	14.38	5.51	0.15	0.15	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	94.30	14.64	19.95	14.51	4.53	0.26	0.52	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	94.88	12.74	21.41	14.37	3.25	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	99.92	16.04	12.72	12.17	4.61	0.74	0.74	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	88.16	17.98	15.79	12.94	3.29	0.00	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	97.19	15.87	21.82	15.87	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	85.35	21.24	15.70	10.42	4.09	0.40	0.53	0.26
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	78.08	18.97	16.34	10.29	3.03	0.20	0.20	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	96.58	35.07	21.35	11.44	1.52	0.00	0.25	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	75.24	9.36	19.51	7.37	4.38	0.60	0.20	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	69.80	7.09	21.26	5.08	1.69	0.15	0.15	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	69.76	6.75	20.66	4.50	1.64	0.00	0.41	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	64.46	10.95	10.95	5.01	1.88	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	49.45	7.63	9.04	3.39	1.98	0.85	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	44.74	8.76	17.06	2.77	2.77	0.00	0.92	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	59.40	12.37	7.42	0.00	4.95	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	54.15	10.06	11.60	6.19	8.12	1.16	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	67.39	8.02	12.84	8.02	3.21	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	46.95	3.48	15.65	3.48	1.74	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	64.77	11.72	18.23	8.46	3.25	0.65	0.33	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	58.89	9.06	15.24	5.35	2.47	0.41	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	46.65	10.00	16.66	0.00	0.00	6.66	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	54.53	6.99	14.82	6.43	4.19	0.28	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	60.47	5.88	19.28	9.15	3.60	0.65	0.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	52.85	6.71	26.00	10.07	0.84	2.52	0.84	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	58.84	9.54	18.13	7.95	2.86	0.64	0.64	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	52.99	6.45	15.96	9.17	3.06	1.02	0.34	1.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	54.29	6.26	25.06	8.35	0.00	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	63.00	10.31	25.20	9.74	2.86	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	49.13	7.99	14.21	6.81	2.66	0.00	0.59	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	60.99	10.16	8.47	5.08	8.47	1.69	1.69	5.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	67.10	12.84	17.81	9.11	3.31	0.00	0.00	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	46.26	8.74	12.20	6.44	3.68	0.92	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	94.83	21.07	26.34	0.00	5.27	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	59.20	11.92	13.45	6.54	1.54	0.38	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	61.28	14.99	14.99	9.13	3.26	0.00	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	80.93	18.06	19.40	5.35	1.34	1.34	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	75.13	11.94	23.50	5.39	2.70	0.77	0.00	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	77.37	15.41	16.09	10.61	4.79	1.03	0.68	1.03
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	67.09	14.91	44.73	7.45	0.00	2.48	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	79.27	9.91	14.63	8.49	2.36	0.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	70.61	10.26	25.35	7.85	5.43	1.21	0.00	1.81
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	75.28	8.65	22.89	6.61	3.05	1.53	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	71.39	11.97	18.75	7.18	3.59	1.20	0.80	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	69.07	14.80	18.75	8.88	0.99	0.99	0.49	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	81.45	15.35	25.97	9.44	1.18	1.18	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	88.10	16.34	14.59	11.67	2.92	1.17	0.00	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	94.36	9.66	26.77	12.73	2.19	1.76	0.88	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	61.03	10.17	16.95	11.87	4.24	0.85	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	71.63	13.13	15.52	11.34	5.37	1.19	1.19	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	66.48	16.01	13.59	11.16	1.94	0.97	0.49	1.46
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	44.51	15.98	13.70	6.85	1.14	0.00	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	57.38	18.30	12.06	7.07	1.25	0.83	0.00	0.42
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	41.60	7.87	5.62	4.50	1.12	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	54.87	32.98	12.37	8.25	0.63	0.32	0.95	0.95
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	51.80	36.34	9.19	6.27	1.25	0.42	0.42	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	58.02	36.90	17.99	6.50	1.97	0.46	0.12	0.23
Hep-2 cells mock treated, biol_rep2	11899-125E9	58.91	32.41	14.18	9.12	2.87	0.34	0.34	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	52.55	33.67	15.47	8.65	2.28	0.23	0.00	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	57.28	28.09	18.69	8.42	2.51	0.22	0.22	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	58.24	32.45	21.92	9.24	3.22	0.00	0.43	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	53.82	34.88	19.38	6.46	1.72	0.22	0.22	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	48.07	26.53	15.82	7.85	1.37	0.75	0.37	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	49.58	26.76	17.67	7.21	3.26	0.17	0.51	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	46.13	23.71	11.53	7.37	3.20	0.00	0.00	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	67.15	3.36	5.60	6.72	0.56	0.00	0.00	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	43.71	3.46	8.22	6.49	0.87	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	68.74	7.93	7.93	7.93	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	57.49	9.52	16.58	8.11	0.71	0.00	0.00	0.35
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	39.23	6.54	12.35	5.09	0.73	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	59.97	21.33	15.39	5.94	1.40	0.35	0.87	0.17
Hepatocyte, donor1	11523-119I2	85.95	56.90	14.53	6.05	0.00	0.00	2.42	2.42
Hepatocyte, donor2	11603-120I1	90.50	42.02	18.31	9.70	4.31	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	85.90	33.13	18.41	13.50	1.23	0.61	1.23	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	53.52	15.66	19.58	6.53	4.57	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	97.53	28.66	26.74	12.93	2.45	0.35	0.35	0.35
Iris Pigment Epithelial Cells, donor1	11530-119I9	71.48	21.95	17.01	7.13	0.55	0.14	0.14	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	28.66	0.00	3.18	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	27.08	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	19.38	1.38	2.77	2.77	1.38	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	7.51	0.00	10.01	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	11.87	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	23.07	0.00	7.69	2.56	2.56	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	27.42	0.00	0.00	4.57	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	34.11	1.62	9.75	1.62	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	10.00	1.67	0.00	1.67	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	18.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	9.26	2.65	3.97	2.65	1.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	25.50	3.33	6.65	0.00	1.11	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	15.71	10.48	15.71	5.24	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	28.34	1.26	5.04	3.15	0.63	0.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	17.01	4.64	4.64	1.55	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	35.53	3.23	5.17	2.58	1.94	0.00	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	28.98	1.61	3.22	3.22	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	59.74	11.95	11.95	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	32.60	1.63	7.33	2.44	0.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	20.15	0.42	4.62	1.68	0.42	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	43.12	14.37	0.00	28.74	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	20.09	0.80	3.21	3.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	21.24	0.92	6.46	1.85	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	0.00	15.08	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	22.66	0.94	6.61	1.89	0.94	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	14.51	2.72	1.81	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	14.74	0.00	0.00	0.00	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	30.13	3.23	1.08	3.23	4.30	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	31.76	1.27	6.35	2.54	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	25.51	1.91	5.10	1.91	1.28	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	20.05	1.82	3.65	1.82	3.65	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	31.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	12.85	2.86	5.00	0.71	0.71	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	26.55	3.32	3.32	0.00	3.32	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	29.32	3.40	5.86	1.23	1.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	22.83	1.76	5.27	0.00	1.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	18.86	0.00	6.29	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	24.34	0.70	7.65	0.70	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	19.92	0.00	6.64	2.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	22.69	3.24	3.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	13.95	0.87	4.36	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	11.25	0.00	4.50	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	17.42	0.00	6.97	3.48	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	6.40	1.07	2.13	1.07	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	23.55	2.77	5.54	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	17.10	0.00	8.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	22.09	0.92	3.68	1.84	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	18.15	0.00	3.03	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	12.42	0.00	0.00	6.21	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	3.17	0.00	1.06	1.06	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	51.33	16.56	10.36	4.08	1.55	0.33	0.08	0.08
Keratinocyte - epidermal, donor2	11349-117G8	16.98	8.20	5.86	1.17	0.00	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	72.32	23.66	17.04	5.30	1.33	0.66	0.38	0.19
Keratinocyte - oral, donor1	11251-116E9	69.36	34.85	20.66	3.18	0.57	0.45	0.45	0.00
Keratocytes, donor1	11527-119I6	68.42	4.13	16.85	2.06	0.34	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	52.73	4.69	23.44	5.86	3.52	1.17	1.17	0.00
Keratocytes, donor3	11688-122I5	52.36	14.42	14.03	2.57	0.40	0.40	0.00	0.00
Krukenberg tumor cell line:HSKTC	10687-109F3	59.34	4.40	17.58	6.59	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	49.62	15.10	11.87	2.16	2.16	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	69.20	16.15	13.96	4.73	1.38	0.12	0.35	0.12
Lens Epithelial Cells, donor3	11690-122I7	118.57	33.70	27.95	16.04	1.92	0.10	0.10	0.10
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	68.06	11.74	7.94	5.10	1.19	0.12	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	49.95	3.91	6.14	5.30	1.12	0.28	0.00	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	68.00	10.55	10.07	7.08	1.42	0.31	0.31	0.31
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	52.16	11.83	7.53	2.69	1.08	0.54	0.00	0.54
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	52.32	2.84	7.56	3.78	0.95	0.32	0.32	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	43.23	5.18	6.36	3.23	0.32	0.32	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	55.40	11.49	6.98	4.92	1.23	0.41	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	40.20	3.29	3.79	4.05	0.51	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	44.20	4.36	6.05	3.24	0.99	0.14	0.14	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	45.49	9.10	9.89	7.52	1.98	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	51.19	8.72	7.56	4.65	0.00	0.19	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	27.96	2.59	6.85	2.96	0.56	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	49.13	9.06	10.80	5.92	1.05	0.00	0.35	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	45.56	5.72	9.30	4.29	0.95	0.24	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	37.63	5.22	4.40	4.26	0.82	0.14	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	55.43	8.62	8.31	10.47	1.23	0.31	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	41.15	3.74	3.74	2.81	0.94	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	39.71	5.67	6.95	5.49	0.37	0.18	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	56.94	8.23	10.20	6.58	2.30	0.66	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	35.73	2.05	6.15	2.93	1.46	0.00	0.00	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	35.10	2.49	5.48	1.99	1.00	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	46.56	7.76	4.36	6.79	1.94	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	51.70	7.00	9.43	8.62	2.15	0.00	0.27	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	52.07	6.51	8.93	4.24	1.06	0.00	0.30	0.30
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	50.29	8.29	6.22	6.74	0.00	0.00	1.04	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	55.49	9.00	7.33	8.38	1.68	0.21	0.21	0.21
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	45.26	4.66	6.32	4.21	0.30	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	51.59	9.63	11.01	6.19	0.69	0.00	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	45.72	5.08	5.27	6.02	0.56	0.00	0.19	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	35.52	4.24	5.20	3.71	1.06	0.00	0.00	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	57.66	7.27	6.30	6.30	1.45	0.48	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	50.28	3.64	2.65	5.95	1.65	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	31.59	2.73	5.45	3.59	0.50	0.12	0.12	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	61.08	11.85	11.11	7.40	1.11	0.00	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	47.44	5.68	5.93	4.45	1.24	0.00	0.25	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	37.26	3.71	5.50	3.02	0.69	0.00	0.14	0.14
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	53.71	10.29	10.61	8.04	1.93	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	57.21	7.91	7.00	6.09	2.13	0.00	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	60.75	6.30	8.54	7.00	1.26	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	50.13	9.60	8.53	4.62	1.07	0.00	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	37.81	1.94	2.91	4.36	1.94	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	27.85	2.80	6.22	2.96	0.93	0.00	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	45.84	5.01	11.10	7.88	0.00	0.00	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	44.75	4.57	2.29	4.25	0.65	0.33	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	23.78	3.53	4.24	4.00	0.94	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	60.76	7.92	9.16	5.45	1.61	0.25	0.12	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	36.63	0.77	3.33	3.84	0.51	0.26	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	38.19	3.28	5.97	5.97	1.19	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	104.24	6.80	9.06	6.80	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	42.96	6.90	13.04	3.84	0.77	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	35.63	8.91	5.94	5.20	0.74	0.00	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	24.54	8.04	9.31	2.12	0.85	0.00	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	37.28	4.92	11.25	3.52	0.70	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	39.23	6.54	9.34	5.60	0.93	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	23.70	7.73	5.15	2.58	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	34.49	4.76	8.33	2.38	0.00	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	46.60	8.60	12.21	4.30	0.45	0.23	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	43.62	13.67	11.92	4.94	1.16	0.29	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	51.32	11.70	13.96	3.15	0.45	0.90	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	42.81	9.08	12.60	4.61	0.27	0.14	0.27	0.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	29.27	6.68	10.27	2.05	0.51	0.51	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	45.17	8.47	15.88	4.23	0.00	0.35	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	46.64	8.66	11.99	4.00	1.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	34.64	11.21	9.17	3.57	1.02	0.51	0.51	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	50.16	8.27	13.34	2.93	1.33	0.80	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	44.59	11.34	11.90	4.53	1.70	0.19	0.19	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	27.61	6.14	13.50	4.29	1.84	0.00	0.61	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	31.80	10.60	11.42	1.63	1.63	0.82	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	49.35	10.41	13.74	4.79	1.87	0.21	0.21	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	40.92	14.01	15.69	4.20	2.24	0.84	0.28	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	42.24	11.33	12.36	6.18	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	47.03	8.42	14.52	2.03	1.45	0.58	1.16	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	40.06	11.66	11.96	2.69	1.20	1.49	0.30	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	40.94	6.09	12.72	2.77	0.55	0.00	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	44.19	9.19	9.54	3.18	0.71	0.35	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	39.09	7.38	11.80	4.06	1.84	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	28.78	5.76	5.76	1.15	1.15	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	43.75	7.29	11.90	3.84	1.92	0.38	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	31.14	7.36	5.10	1.13	1.13	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	41.02	7.38	14.77	0.82	0.82	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	36.60	11.30	12.20	1.81	1.36	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	38.78	4.31	7.90	2.87	0.72	0.00	0.72	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	55.27	8.22	20.17	4.48	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	36.04	4.09	10.03	2.60	0.74	0.37	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	34.03	6.46	13.35	3.45	0.86	0.00	0.43	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	43.67	5.99	16.27	5.99	1.71	0.86	1.71	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	38.98	7.33	11.66	3.66	1.67	1.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	28.96	6.03	9.65	2.41	1.21	0.00	0.60	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	33.42	7.11	12.09	4.27	0.71	0.00	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	34.72	7.22	12.37	2.75	0.34	0.34	0.00	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	32.20	8.59	7.51	3.76	2.15	0.54	0.54	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	31.65	8.08	10.77	2.69	0.00	0.67	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	41.12	9.63	13.33	1.85	0.37	0.00	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	44.19	5.81	15.12	6.98	1.16	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	26.44	5.29	5.29	2.12	1.06	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	37.61	4.40	12.00	2.80	0.40	1.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	25.44	3.63	8.00	3.63	1.45	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	36.79	7.67	9.20	4.60	0.00	0.00	0.00	0.77
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	36.01	5.43	9.87	2.47	1.48	0.49	0.99	0.49
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	24.46	3.76	4.70	3.76	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	46.26	10.56	11.06	4.02	0.00	0.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	34.25	8.11	10.36	5.41	0.90	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	30.98	8.61	5.16	1.72	0.00	0.00	0.00	1.72
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	35.18	5.79	9.80	5.79	0.00	0.89	0.00	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	48.49	6.65	7.82	3.91	0.00	0.00	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	23.75	7.92	11.22	1.32	0.66	0.66	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	37.36	8.30	12.45	8.30	1.04	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	45.94	13.13	13.56	5.25	0.00	0.00	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	40.26	10.62	7.83	5.59	1.12	0.56	1.68	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	43.72	9.27	16.34	4.86	1.32	0.88	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	38.19	9.26	11.57	3.47	0.39	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	26.33	8.61	10.63	4.05	1.52	0.51	0.51	0.51
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	41.33	8.17	15.86	3.84	0.48	0.48	0.48	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	34.98	9.94	13.12	7.16	0.40	0.80	1.19	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	41.93	6.68	7.29	2.43	1.82	1.82	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	26.98	5.53	8.30	2.08	0.69	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	40.28	8.74	12.54	4.18	0.38	0.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	33.05	9.30	8.78	3.10	2.58	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	40.51	6.65	9.07	5.44	1.21	0.00	0.00	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	46.90	6.97	13.63	4.12	0.63	0.63	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	33.05	4.80	7.46	4.80	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	36.78	7.47	9.77	4.60	0.57	0.00	0.00	0.57
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	36.51	7.20	10.80	6.17	2.57	0.51	0.51	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	26.17	7.78	7.78	5.66	1.41	1.41	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	32.35	10.21	9.08	3.97	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	37.03	6.66	14.98	3.74	0.83	0.83	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	33.67	7.83	4.70	0.78	1.57	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	35.91	5.85	8.35	3.76	0.84	0.42	0.84	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	41.82	9.29	9.76	3.25	0.00	0.00	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	34.12	6.69	4.01	0.67	0.67	0.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	41.70	6.95	11.23	5.35	1.60	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	30.31	8.08	10.10	5.25	0.00	0.00	0.00	0.81
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	32.12	3.67	11.93	2.75	0.00	0.92	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	32.01	4.45	4.45	3.56	0.00	0.00	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	42.17	8.55	11.97	3.42	2.28	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	33.74	9.97	9.97	3.83	0.00	0.00	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	35.57	10.40	9.30	8.21	0.55	0.55	0.55	0.55
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	39.64	7.13	11.58	4.01	0.89	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	35.61	9.36	12.22	5.72	0.52	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	33.82	5.30	11.27	2.65	1.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	58.20	4.16	6.24	4.16	0.00	2.08	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	66.55	17.55	17.09	3.87	0.23	0.23	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	70.28	17.62	17.25	6.79	0.55	0.37	0.00	0.18
Macrophage - monocyte derived, donor3	11389-118C3	53.35	12.19	14.94	2.88	0.79	0.13	0.13	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	97.18	23.90	19.65	11.15	7.43	0.53	0.00	0.53
Mallassez-derived cells, donor2	11929-125I3	97.61	36.76	20.76	16.95	5.07	0.48	0.00	0.00
Mallassez-derived cells, donor3	11930-125I4	89.23	37.53	20.29	12.09	4.59	0.28	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	68.55	33.28	16.94	5.48	1.49	0.30	0.00	0.50
Mammary Epithelial Cell, donor2	11350-117G9	49.22	30.69	11.29	6.37	2.61	0.00	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	27.69	7.48	5.99	1.50	0.75	0.00	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	201.35	21.02	8.81	22.37	2.71	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	64.34	12.44	13.30	3.68	0.32	0.32	0.00	0.11
Mast cell, donor2	11565-120D8	104.01	25.26	29.72	4.75	0.59	0.00	0.00	0.00
Mast cell, donor3	11566-120D9	110.99	26.56	28.14	4.28	0.90	0.23	0.23	0.00
Mast cell, donor4	11567-120E1	88.64	18.26	25.18	6.03	0.53	0.00	0.00	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	75.41	24.06	15.53	3.88	0.55	0.11	0.00	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	63.04	5.25	9.34	4.09	0.00	0.58	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	65.97	19.96	13.31	2.18	0.57	0.00	0.23	0.11
Mast cell, expanded, donor8	11941-126A6	65.78	6.19	14.73	2.51	1.17	0.00	0.00	0.17
Melanocyte - dark, donor1	11502-119F8	92.63	16.22	11.34	6.67	1.29	0.30	0.20	0.10
Melanocyte - dark, donor2	11582-120F7	56.76	22.15	10.38	9.00	1.38	0.69	0.69	0.35
Melanocyte - dark, donor3	11663-122F7	79.32	24.77	21.08	6.37	1.16	0.29	0.14	0.14
Melanocyte - light, donor1	11274-116H5	31.73	6.82	7.99	2.82	0.47	0.00	0.00	0.00
Melanocyte - light, donor2	11351-117H1	19.11	6.14	5.46	3.41	1.36	0.00	0.00	0.00
Melanocyte - light, donor3	11423-118G1	15.61	6.94	10.41	2.60	0.87	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	58.52	17.18	16.66	4.79	0.94	0.42	0.42	0.62
Melanocyte, donor2 (MC+2)	12739-135I3	51.91	19.09	10.22	4.30	1.08	0.00	0.27	0.54
Melanocyte, donor3 (MC+3)	12837-137B2	64.55	16.34	12.32	6.70	1.07	0.00	0.54	0.00
Meningeal Cells, donor1	11493-119E8	83.12	17.62	18.11	8.93	2.48	0.12	0.00	0.12
Meningeal Cells, donor2	11573-120E7	82.31	15.85	12.76	9.68	3.96	0.00	0.44	0.00
Meningeal Cells, donor3	11654-122E7	89.49	30.40	16.63	8.48	4.40	0.24	0.08	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	95.24	40.78	21.39	7.41	0.86	0.00	0.00	0.86
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	97.81	43.77	18.11	13.38	2.62	0.20	0.20	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	15.77	5.26	5.26	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	31.40	2.62	7.85	9.16	1.31	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	76.78	30.86	18.66	4.31	2.15	0.72	0.72	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	64.17	35.58	13.34	9.32	2.33	0.21	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	46.24	18.10	12.06	3.02	2.51	0.00	0.50	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	65.27	9.89	16.48	6.15	0.44	0.44	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	59.91	8.04	13.88	5.84	1.46	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	53.61	6.34	9.62	5.12	0.82	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	68.70	67.31	17.04	7.89	0.83	0.14	0.14	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	22.68	6.69	11.52	4.09	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	80.52	47.24	18.16	7.37	1.18	0.26	0.39	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	37.69	11.57	11.87	4.45	0.59	0.00	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	14.01	7.01	4.67	4.67	2.34	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	63.40	11.53	12.17	6.40	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	105.62	52.10	26.23	12.41	1.42	0.35	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	76.62	41.59	20.95	7.51	0.94	0.31	0.63	0.31
Mesenchymal stem cells - umbilical, donor0	11214-116A8	71.84	25.40	15.24	2.90	0.73	0.73	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	81.14	44.55	24.66	12.20	2.12	0.27	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	104.10	28.53	26.52	11.51	7.01	0.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	61.35	23.85	15.54	7.15	2.02	0.36	0.29	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	103.97	12.15	24.31	10.80	2.70	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	83.73	11.08	18.47	7.39	0.99	0.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	69.79	7.36	19.14	7.36	1.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	51.86	0.00	13.83	6.91	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	60.75	9.30	14.88	5.89	1.24	0.62	0.31	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	47.92	8.92	12.24	3.94	0.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	30.11	0.00	2.32	9.26	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	74.08	9.76	22.52	5.01	0.50	0.50	0.50	0.25
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	76.80	3.72	11.17	9.31	1.40	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	19.47	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	56.90	8.13	15.04	4.47	0.41	0.20	0.20	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	60.98	4.75	10.30	10.69	0.40	0.00	0.00	0.40
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	25.65	0.00	0.00	17.10	8.55	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	34.51	4.42	12.39	1.77	0.88	0.00	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	53.57	13.68	9.50	6.08	0.38	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	50.00	1.32	10.53	9.21	1.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	50.72	9.76	12.73	4.88	0.42	0.85	0.21	0.21
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	47.88	2.76	4.60	9.21	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	46.79	4.47	11.92	4.77	0.60	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	41.92	0.00	8.38	8.38	3.35	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	43.41	10.04	12.80	3.76	1.00	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	53.48	6.18	13.55	6.65	0.95	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	39.25	2.76	11.06	4.98	1.66	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	37.07	9.44	11.05	6.45	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	47.54	7.15	10.94	4.63	0.84	0.21	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	44.84	6.73	8.76	5.30	0.41	0.00	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	42.05	10.51	11.37	4.08	0.64	0.43	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	52.24	5.33	10.89	7.56	1.11	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	10.32	10.32	10.32	0.00	10.32	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	34.17	8.76	11.17	2.63	0.88	0.44	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	41.06	3.04	8.62	8.11	2.03	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	36.45	0.00	8.28	6.63	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	44.30	7.88	9.78	5.71	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	48.82	4.71	11.47	6.47	0.29	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	39.25	0.00	11.99	4.36	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	33.16	11.53	12.97	4.32	0.00	0.00	0.00	0.48
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	44.43	5.20	10.41	10.41	1.60	0.00	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	42.51	4.11	20.57	1.37	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	43.55	8.51	12.51	5.51	1.00	0.50	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	26.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	38.73	2.04	4.08	4.08	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	58.24	10.07	14.01	10.07	0.88	0.00	1.31	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	36.42	5.52	11.04	6.62	4.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	40.34	3.84	12.81	3.20	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	57.02	15.37	14.88	7.44	0.99	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	61.24	0.00	12.53	10.44	2.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	24.31	2.21	8.84	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	48.89	12.31	9.57	4.79	0.34	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	57.77	4.81	14.44	11.82	1.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	37.64	1.78	10.30	5.68	1.78	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	47.41	9.26	8.98	6.45	1.12	1.12	0.28	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	72.32	3.74	14.55	9.98	2.08	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	51.28	1.75	8.16	9.32	0.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	52.49	6.64	13.57	5.13	1.51	0.30	0.60	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	68.45	8.35	24.21	11.69	1.25	0.00	1.25	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	0.00	36.09	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	67.42	6.46	12.01	4.62	1.85	0.00	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	77.97	7.97	15.94	10.81	3.41	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	53.61	4.01	18.52	3.87	1.66	0.14	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	48.98	4.92	15.55	5.44	0.78	0.52	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	69.07	3.43	22.74	8.58	1.29	0.43	0.00	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	44.46	1.91	17.79	3.81	1.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	64.05	5.07	13.88	4.80	1.07	0.00	0.27	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	64.66	8.98	16.76	8.68	0.90	0.30	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	51.84	4.24	13.00	4.10	0.85	0.00	0.14	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	52.24	8.92	7.64	4.14	1.59	0.32	0.64	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	69.44	8.85	18.80	7.96	1.11	0.22	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	52.33	2.65	10.24	4.93	1.52	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	54.55	8.52	15.63	3.98	0.85	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	60.22	8.60	16.71	6.39	1.23	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	33.24	3.91	5.21	3.26	1.30	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	49.40	7.35	15.29	5.29	1.18	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	68.91	6.92	20.76	3.17	0.58	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	61.00	7.42	15.66	2.89	1.24	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	50.92	2.98	11.32	4.47	0.30	0.00	0.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	30.14	11.30	11.30	7.53	0.00	3.77	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	46.34	10.69	19.60	3.56	1.78	1.78	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	81.16	14.13	22.01	6.24	0.66	1.31	0.66	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	62.07	10.52	21.04	3.16	1.05	1.05	0.00	1.05
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	70.97	15.42	18.38	6.92	0.99	0.20	0.40	0.40
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	76.37	11.18	18.63	4.66	2.79	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	58.58	18.40	19.15	4.88	0.38	0.75	0.38	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	48.74	7.72	11.99	3.20	1.33	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	55.53	16.06	16.85	3.96	1.24	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	41.99	11.79	10.31	3.68	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	71.82	9.16	16.49	6.60	0.37	1.10	1.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	51.33	3.11	18.67	1.56	0.00	1.56	0.00	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	75.36	26.72	29.93	5.34	0.53	0.53	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	46.37	7.73	3.86	0.00	0.00	0.00	3.86	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	62.62	4.04	16.16	4.04	3.03	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	62.40	9.28	9.28	3.79	0.84	0.42	0.84	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	61.29	28.60	12.26	8.17	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	45.14	13.35	12.72	3.81	0.64	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	63.17	31.58	21.06	4.86	0.81	0.81	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	43.80	19.64	16.61	9.06	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	22.84	11.42	22.84	17.13	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	58.72	35.89	6.52	22.84	3.26	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	80.79	14.26	14.26	23.76	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	12.55	12.55	25.10	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	125.60	49.33	21.11	16.37	3.45	0.22	0.65	0.43
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	99.82	33.45	19.34	9.93	1.05	0.52	1.05	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	28.03	11.35	4.00	4.00	0.00	0.00	0.67	0.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	45.49	7.10	7.10	2.92	2.50	0.42	0.00	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	64.84	33.85	12.74	4.37	1.33	0.38	0.57	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	95.75	27.13	23.94	4.79	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	18.36	6.80	4.08	3.40	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	66.16	62.48	22.05	1.84	1.84	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	25.53	8.79	7.53	2.93	0.84	0.00	0.00	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	52.53	13.02	9.30	4.42	1.39	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	31.89	10.54	5.13	5.40	0.54	0.27	0.54	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	60.97	18.92	17.45	4.84	1.26	0.21	0.63	0.42
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	122.48	211.56	33.40	0.00	0.00	11.13	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	38.72	29.29	8.44	3.47	1.49	0.50	0.50	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	45.20	28.15	7.04	4.87	0.54	0.27	0.81	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	39.44	17.23	8.39	4.31	1.13	0.68	0.45	0.45
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	28.41	16.33	7.51	4.74	0.65	0.16	0.82	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	61.24	30.44	15.86	6.01	1.28	0.18	0.36	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	33.42	21.75	7.43	4.24	1.06	0.00	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	24.01	16.81	5.40	1.80	1.20	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	46.60	75.15	10.83	2.63	1.97	1.97	2.95	1.31
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	31.39	13.34	5.20	3.42	1.30	0.00	0.33	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	63.14	23.81	13.93	7.41	1.06	0.53	0.00	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	35.16	13.36	7.03	2.81	0.70	0.00	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	38.62	19.31	5.06	3.22	0.46	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	43.38	18.96	10.93	5.78	1.93	0.00	0.64	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	62.42	64.49	11.04	4.14	1.72	2.76	3.79	4.14
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	139.06	118.84	22.76	2.53	0.00	0.00	5.06	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	69.73	15.15	14.70	6.91	1.78	0.00	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	44.03	16.51	8.89	7.62	1.27	0.42	0.42	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	28.96	24.45	6.88	2.85	0.95	0.95	1.19	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	58.38	28.33	11.59	6.01	0.43	0.00	0.43	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	144.44	334.03	36.11	27.08	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	57.98	15.99	11.66	4.33	1.67	0.33	0.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	68.08	9.92	10.82	8.12	1.80	0.00	0.45	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	43.25	13.89	7.94	6.75	1.59	0.00	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	36.22	24.14	5.57	1.86	0.93	1.86	1.86	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	63.19	31.03	15.13	6.81	1.89	0.38	0.00	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	47.58	12.71	8.47	8.15	1.30	0.00	0.00	0.65
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	35.30	10.46	6.54	3.92	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	84.13	20.35	19.00	9.50	1.36	0.00	0.45	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	40.57	17.64	4.41	6.17	0.88	0.00	1.76	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	37.23	16.62	10.64	0.66	0.00	0.66	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	54.07	24.31	12.40	8.93	0.99	0.00	0.50	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	39.81	9.19	9.57	8.80	1.53	0.38	0.77	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	51.42	26.31	13.31	3.93	1.21	0.91	0.91	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	85.54	23.21	15.91	11.05	3.09	0.22	0.00	0.66
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	32.53	12.20	7.45	4.74	2.03	0.00	0.68	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	102.19	143.07	40.88	5.11	0.00	5.11	5.11	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	57.31	20.12	18.29	8.54	0.00	0.61	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	50.67	12.90	13.22	8.81	1.57	0.63	0.31	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	37.53	13.32	8.17	3.63	0.61	0.00	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	58.54	20.57	10.28	12.66	0.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	79.36	71.42	12.47	6.80	0.00	3.40	4.53	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	80.93	91.04	20.23	5.06	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	96.77	39.50	23.23	18.39	5.34	0.87	0.12	0.00
Myoblast, donor2	11322-117D8	72.30	38.93	19.18	6.52	1.92	0.96	0.38	0.77
Myoblast, donor3	11398-118D3	81.22	31.28	20.35	11.10	2.19	0.17	0.34	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	109.45	13.57	22.18	12.11	6.71	0.29	0.29	0.00
Natural Killer Cells, donor1	11230-116C6	128.54	13.22	11.99	38.13	52.28	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	113.69	14.47	10.55	33.47	47.95	0.30	0.00	0.30
Natural Killer Cells, donor3	11387-118C1	117.43	12.88	11.41	33.13	36.07	0.37	0.18	0.00
Neural stem cells, donor1	11275-116H6	103.80	28.67	18.87	7.98	5.08	0.00	0.36	0.00
Neural stem cells, donor2	11352-117H2	159.83	26.96	36.59	9.63	5.78	0.00	0.00	1.93
Neurons, donor1	11494-119E9	87.62	9.10	25.03	12.52	5.69	0.00	0.00	0.00
Neurons, donor2	11574-120E8	109.86	12.11	26.86	7.49	0.88	1.10	0.22	0.00
Neurons, donor3	11655-122E8	102.77	9.04	21.38	8.22	1.64	0.82	1.64	0.82
Neutrophils, donor1	11233-116C9	410.18	10.21	44.54	35.26	7.42	0.00	0.93	0.00
Neutrophils, donor2	11314-117C9	275.39	11.60	28.99	11.60	8.70	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	543.04	14.05	46.42	75.13	20.16	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	71.48	66.73	17.69	3.92	0.36	0.12	0.24	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	47.21	23.44	6.84	3.26	0.00	0.33	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	48.33	25.67	12.03	3.01	0.40	0.20	0.20	0.00
Olfactory epithelial cells, donor1	11933-125I7	47.08	24.09	9.64	3.58	0.69	0.28	0.69	0.00
Olfactory epithelial cells, donor2	11934-125I8	72.37	43.13	14.47	4.63	1.01	1.45	1.01	1.16
Olfactory epithelial cells, donor3	11935-125I9	63.00	34.62	13.51	6.92	1.14	0.91	0.23	0.57
Olfactory epithelial cells, donor4	11936-126A1	67.89	32.63	15.78	3.60	0.49	0.49	0.49	0.78
Oligodendrocyte - precursors, donor1	11496-119F2	106.52	17.45	34.30	8.43	1.81	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	60.83	38.07	16.16	8.72	2.55	0.00	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	35.44	8.00	11.43	6.86	2.29	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	28.55	14.90	8.69	2.48	1.24	0.00	0.62	0.00
Osteoblast, donor1	11277-116H8	45.34	9.77	13.88	3.71	0.59	0.00	0.20	0.00
Osteoblast, donor2	11354-117H4	105.35	56.19	27.39	7.73	1.40	0.70	0.00	0.00
Osteoblast, donor3	11426-118G4	114.10	22.04	23.46	8.00	2.31	0.00	0.18	0.36
Pancreatic stromal cells, donor1	11249-116E7	71.52	55.60	19.29	5.90	1.52	0.34	0.08	0.17
Pericytes, donor1	11491-119E6	21.47	2.89	8.46	2.34	0.56	0.00	0.11	0.00
Pericytes, donor2	11571-120E5	35.54	4.98	7.92	2.72	0.45	0.23	0.00	0.23
Pericytes, donor3	11652-122E5	63.68	12.21	14.44	6.31	0.81	0.41	0.41	0.00
Perineurial Cells, donor1	11499-119F5	93.02	35.38	20.12	7.69	1.58	0.23	0.11	0.11
Perineurial Cells, donor2	11579-120F4	84.19	24.75	16.93	6.72	1.47	0.28	0.00	0.00
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	103.59	11.79	17.21	14.98	10.20	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	92.56	10.77	11.75	13.47	7.35	0.00	0.24	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	91.24	6.47	11.26	15.40	9.32	0.13	0.13	0.13
Placental Epithelial Cells, donor1	11278-116H9	46.40	10.28	15.31	6.46	1.20	0.24	0.00	0.24
Placental Epithelial Cells, donor2	11355-117H5	38.81	16.63	8.87	4.44	1.11	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	28.27	12.96	11.58	1.37	0.79	0.59	0.20	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	87.34	48.10	15.82	23.10	3.16	2.22	0.32	0.63
Preadipocyte - breast, donor1	11467-119B9	96.98	43.71	16.13	15.57	3.00	0.38	0.56	0.75
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	155.20	35.37	25.45	29.89	3.39	0.00	0.13	0.00
Preadipocyte - breast, donor2	11328-117E5	113.70	50.88	18.91	18.91	3.83	2.93	0.45	0.45
Preadipocyte - omental, donor1	11468-119C1	124.46	61.59	23.23	18.65	3.41	0.64	0.64	0.11
Preadipocyte - omental, donor2	11329-117E6	135.31	43.21	29.24	21.39	2.62	0.44	0.44	0.00
Preadipocyte - omental, donor3	11403-118D8	119.47	43.40	26.79	18.48	3.29	0.86	0.29	0.57
Preadipocyte - perirenal, donor1	11469-119C2	52.17	22.64	15.75	19.69	2.95	0.00	0.98	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	46.37	15.97	13.21	6.45	0.31	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	85.71	50.29	20.36	10.80	0.89	1.06	0.53	0.53
Preadipocyte - subcutaneous, donor3	11428-118G6	82.59	56.02	16.86	7.66	2.04	1.02	0.51	0.34
Preadipocyte - visceral, donor1	11280-116I2	84.58	73.21	24.87	6.43	1.02	0.37	0.37	0.28
Preadipocyte - visceral, donor2	11357-117H7	59.36	40.04	13.35	4.14	0.92	0.00	0.46	0.00
Preadipocyte - visceral, donor3	11429-118G7	56.22	43.05	14.00	6.06	1.46	0.73	0.00	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	51.89	12.37	12.07	8.15	3.17	0.30	0.15	0.15
Prostate Epithelial Cells, donor2	11331-117E8	53.49	10.97	11.24	7.85	1.90	0.54	0.14	0.00
Prostate Epithelial Cells, donor3	11404-118D9	65.89	15.25	15.49	4.29	0.67	0.18	0.24	0.18
Prostate Stromal Cells, donor1	11254-116F3	65.83	28.13	18.68	5.81	1.14	0.57	0.23	0.23
Prostate Stromal Cells, donor2	11332-117E9	74.41	25.64	15.06	8.61	0.90	0.90	0.54	0.18
Prostate Stromal Cells, donor3	11405-118E1	74.24	40.46	18.25	6.57	1.46	0.63	0.31	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	46.72	1.46	16.79	3.65	0.00	0.00	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	60.44	9.63	15.80	3.47	0.83	0.07	0.00	0.07
Renal Epithelial Cells, donor1	11517-119H5	28.91	1.01	9.13	2.03	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	35.57	1.42	9.96	2.85	0.00	0.71	0.00	0.00
Renal Epithelial Cells, donor3	11678-122H4	67.97	11.96	17.68	4.13	1.16	0.00	0.21	0.53
Renal Glomerular Endothelial Cells, donor1	11514-119H2	46.98	3.40	6.81	7.49	0.68	0.00	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	67.38	3.91	7.95	6.60	1.62	0.27	0.00	0.27
Renal Glomerular Endothelial Cells, donor3	11675-122H1	79.70	10.66	11.10	7.77	2.22	0.22	0.22	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	29.28	1.33	2.66	4.66	1.33	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	44.46	3.52	11.22	4.62	0.22	0.00	0.00	0.22
Renal Mesangial Cells, donor2	11598-120H5	52.04	5.02	13.79	5.64	0.63	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	22.19	1.94	11.10	1.39	0.28	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	81.60	9.13	20.94	4.03	1.88	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	39.64	5.06	13.92	3.37	0.84	0.42	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	46.48	2.89	13.11	3.09	0.58	0.19	0.19	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	61.71	13.22	23.85	3.11	0.00	0.26	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	50.31	8.24	11.37	3.13	1.71	0.00	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	19.55	3.09	12.35	1.03	0.00	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	59.21	16.31	13.05	3.51	1.00	0.00	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	119.74	57.33	29.00	10.56	1.47	0.13	0.40	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	65.22	11.61	16.97	13.40	0.89	1.79	0.00	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	44.03	18.71	7.15	6.60	2.20	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	51.04	16.24	16.82	12.18	3.48	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	72.94	9.75	16.51	9.88	4.55	0.26	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	52.73	7.85	15.49	6.36	2.48	0.00	0.10	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	58.22	12.16	15.50	8.81	3.12	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	77.53	13.02	22.20	8.31	2.48	0.50	0.00	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	62.35	8.97	17.25	7.58	2.45	0.23	0.23	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	62.87	14.33	19.18	10.86	1.62	0.23	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	53.67	5.48	13.14	7.53	4.38	0.14	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	48.56	9.23	10.59	7.41	2.27	0.00	0.45	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	62.72	8.06	19.17	9.68	2.33	0.18	0.18	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	48.20	5.45	12.62	8.75	2.44	0.29	0.29	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	49.04	7.30	12.56	6.33	2.15	0.00	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	59.52	11.06	15.05	7.97	3.32	0.22	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	47.99	7.07	8.79	8.03	2.68	0.00	0.76	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	57.95	6.71	16.49	7.64	2.24	0.00	0.00	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	65.96	14.66	18.98	11.27	3.38	0.19	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	57.86	6.10	12.61	10.22	4.51	0.27	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	55.87	7.59	15.96	8.47	2.92	0.10	0.19	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	52.51	11.46	15.28	8.40	3.06	0.00	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	53.18	6.73	13.56	10.36	2.56	0.11	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	49.89	6.45	12.05	10.09	3.08	0.28	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	62.55	9.06	14.87	8.89	3.76	0.17	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	61.26	5.65	11.67	11.12	3.46	0.18	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	53.35	7.97	14.47	6.50	2.70	0.25	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	64.07	10.48	19.07	10.61	2.55	0.00	0.40	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	46.47	7.55	9.67	10.38	3.30	0.24	0.24	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	53.97	6.15	12.50	8.53	4.37	0.00	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	52.15	11.22	16.37	8.89	2.57	0.23	0.23	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	52.05	7.88	15.76	8.71	2.07	0.41	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	57.51	10.18	10.84	7.30	4.87	0.00	0.22	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	66.84	10.03	14.00	7.73	3.34	0.42	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	55.31	7.27	13.19	11.44	4.04	0.00	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	56.37	8.69	13.79	9.03	2.38	0.00	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	62.27	9.25	21.01	10.80	3.08	0.19	0.39	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	43.50	8.25	8.08	8.60	3.78	0.34	0.34	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	58.57	7.96	13.72	7.96	3.29	0.14	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	60.91	12.97	13.79	9.52	2.79	0.16	0.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	41.59	4.77	9.37	9.20	3.07	0.17	0.17	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	59.18	8.14	19.83	7.25	2.96	0.30	0.30	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	56.78	9.06	16.53	8.00	1.60	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	57.24	4.98	13.96	9.54	2.21	0.00	0.14	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	53.10	7.14	15.24	6.67	2.14	0.24	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	67.92	6.85	16.93	11.08	3.43	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	45.96	5.18	12.05	6.22	1.88	0.38	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	55.20	10.48	12.23	9.08	2.10	0.00	0.35	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	61.05	11.48	11.48	7.56	3.02	0.91	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	41.49	5.75	11.75	6.73	2.20	0.49	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	95.77	20.81	31.44	12.81	3.93	0.00	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	68.75	11.56	18.25	7.91	1.22	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	41.89	7.84	13.26	9.34	2.11	0.30	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	52.02	6.33	14.02	7.46	3.17	0.23	0.00	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	71.29	10.18	21.27	10.18	0.90	0.60	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	62.93	10.51	18.18	8.74	1.77	0.12	0.00	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	56.56	9.82	13.87	8.54	3.84	0.21	0.00	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	60.70	12.02	15.63	8.41	2.40	0.00	1.80	0.00
Schwann Cells, donor1	11498-119F4	39.49	3.01	12.04	4.14	0.94	0.38	0.00	0.00
Schwann Cells, donor2	11578-120F3	54.44	3.40	17.01	3.40	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	76.68	18.40	12.93	6.35	1.31	0.88	0.44	0.44
Sebocyte, donor1	11220-116B5	60.80	18.08	20.82	6.03	1.10	0.00	0.55	0.00
Sebocyte, donor2	11301-117B5	41.36	11.49	11.95	4.60	0.92	0.92	0.00	0.00
Sebocyte, donor3	11378-118B1	34.21	10.72	8.66	4.33	1.03	0.21	0.00	0.00
Sertoli Cells, donor1	11255-116F4	91.11	29.82	29.82	8.28	4.97	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	59.31	33.89	25.42	14.12	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	56.57	16.89	13.72	2.02	0.18	0.09	0.26	0.18
Skeletal Muscle Cells, donor2	11358-117H8	22.41	2.17	7.23	1.45	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	43.47	9.20	7.52	2.51	0.84	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	71.79	31.73	16.02	7.38	0.47	0.31	0.16	0.00
Skeletal Muscle Cells, donor5	11455-119A6	67.34	30.17	15.01	6.99	0.59	0.15	0.30	0.45
Skeletal Muscle Cells, donor6	11459-119B1	88.80	28.32	18.62	7.08	2.00	0.92	0.00	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	102.70	72.20	26.34	8.82	0.25	0.38	0.38	0.25
Skeletal Muscle Satellite Cells, donor2	11321-117D7	82.90	40.95	16.55	4.42	1.57	0.29	0.00	0.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	91.17	29.47	19.54	7.44	0.60	0.40	0.60	0.20
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	73.55	27.30	16.26	9.10	0.84	0.34	0.25	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	31.85	2.90	8.69	2.17	1.45	0.00	0.72	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	35.50	8.94	8.53	2.89	1.38	0.00	0.00	0.14
Skin - palm, donor1	10286-104F7	80.58	24.17	8.06	5.37	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	39.79	7.50	10.52	5.91	0.72	0.14	0.00	0.43
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	66.25	25.35	14.72	12.27	0.82	0.00	0.00	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	42.19	10.78	6.88	5.06	0.39	0.13	0.13	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	88.97	21.55	16.82	9.87	1.81	0.28	0.42	0.70
Small Airway Epithelial Cells, donor2	11334-117F2	76.24	9.14	13.64	9.14	1.13	0.28	0.00	0.14
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	101.28	21.99	29.81	11.42	1.48	0.00	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	89.79	10.27	23.01	7.05	1.05	0.30	0.37	0.45
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	56.78	24.69	14.50	8.02	2.78	0.93	0.62	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	67.14	21.34	11.12	9.78	2.22	0.00	0.22	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	61.72	23.51	18.81	7.64	0.59	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	58.34	33.15	21.88	5.30	0.88	0.22	0.00	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	59.46	12.99	9.06	8.27	1.58	0.00	0.39	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	64.90	15.45	19.31	8.50	0.77	0.00	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	54.04	19.01	5.00	8.01	0.00	0.00	1.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	64.81	16.77	13.17	7.19	2.00	0.27	0.27	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	79.80	52.53	16.85	9.31	0.66	1.11	0.22	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	113.82	27.78	19.59	20.36	7.17	0.00	0.26	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	64.47	30.61	24.42	10.74	2.28	0.65	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	87.71	34.85	15.65	9.16	0.89	0.30	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	75.74	18.79	19.93	11.82	2.56	0.28	0.14	0.28
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	42.78	6.18	13.50	3.74	0.81	0.00	0.00	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	64.24	32.88	14.00	4.26	0.91	0.30	0.30	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	42.94	18.94	14.14	4.80	0.76	0.00	0.00	0.25
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	0.00	30.60	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	48.16	5.25	5.25	4.77	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	62.82	38.05	20.35	8.55	0.88	0.15	0.29	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	60.91	31.42	14.64	9.26	1.72	0.00	0.86	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	75.57	28.97	16.48	6.93	2.52	0.73	0.63	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	65.43	7.89	16.71	9.74	2.32	0.31	0.00	0.15
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	57.13	11.86	11.86	9.70	2.16	0.00	1.08	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	59.77	11.36	11.95	6.57	2.39	0.00	0.30	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	38.58	4.10	11.95	4.10	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	70.60	45.15	15.00	5.42	0.63	0.00	0.08	0.16
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	72.16	51.13	18.72	6.94	2.21	0.70	0.10	0.10
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	66.67	21.39	17.75	7.74	2.05	0.46	0.23	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	33.81	12.68	10.87	6.64	1.81	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	94.31	29.41	26.23	8.48	1.06	0.26	0.00	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	72.97	34.62	18.91	8.92	1.86	0.40	0.00	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	61.61	28.80	15.90	6.89	1.00	0.50	0.38	0.25
Smooth Muscle Cells - Prostate, donor3	11465-119B7	59.36	59.86	17.00	6.85	0.76	0.00	0.25	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	82.62	38.45	24.27	12.21	1.36	0.00	0.15	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	44.26	12.75	10.50	3.75	1.50	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	197.71	173.16	109.84	12.92	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	56.74	17.67	15.81	9.30	0.47	0.00	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	58.06	24.74	10.60	9.09	2.02	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	63.62	14.10	13.16	10.66	3.13	0.63	0.00	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	30.68	7.96	12.68	4.72	0.59	0.00	0.00	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	95.47	38.15	25.58	9.16	0.67	0.00	0.00	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	74.28	34.57	14.48	6.07	0.47	0.00	0.00	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	75.27	13.82	12.95	11.80	3.45	0.00	0.14	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	60.17	14.02	12.24	7.39	2.29	0.00	0.25	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	43.81	9.59	9.97	3.38	1.32	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	101.17	41.08	21.38	6.85	1.68	0.14	0.00	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	98.79	41.48	21.70	10.05	0.84	0.42	0.17	0.34
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	35.24	0.95	10.00	1.90	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	73.40	13.70	19.08	9.05	2.94	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	71.15	47.06	19.66	11.71	3.54	0.22	0.00	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	52.96	31.89	11.70	3.22	0.59	0.59	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	60.45	37.32	12.83	5.64	0.97	0.19	0.78	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	40.46	23.27	11.11	6.88	0.53	1.32	1.59	0.26
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	44.26	76.25	10.04	6.70	1.12	2.98	1.12	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	53.18	37.73	15.81	13.30	1.80	2.52	1.08	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	47.41	21.29	11.64	11.64	2.27	1.14	0.57	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	61.05	35.05	18.91	6.70	0.39	0.79	1.18	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	46.98	50.03	12.44	4.57	1.78	1.52	0.76	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	46.72	35.94	16.37	3.99	0.00	0.40	0.80	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	45.56	34.69	10.87	7.11	0.42	1.25	1.67	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	53.17	31.63	10.54	4.13	1.83	1.38	0.00	0.46
Synoviocyte, donor1	11291-117A4	93.75	49.82	21.55	14.98	2.02	0.17	0.00	0.50
Synoviocyte, donor2	11368-117I9	64.37	64.20	13.24	4.86	0.84	1.34	0.50	0.17
Synoviocyte, donor3	11440-118H9	54.51	45.35	15.64	2.23	0.22	1.56	0.67	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	48.95	7.86	15.72	6.43	1.43	0.36	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	19.82	3.96	9.91	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	30.33	5.56	10.19	2.32	0.46	0.00	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	57.56	15.63	16.49	4.01	0.57	0.14	0.14	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	31.70	3.87	8.12	1.93	0.00	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	34.93	4.01	8.02	1.72	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	111.58	53.02	24.97	10.58	1.23	0.12	0.12	0.49
Urethra, donor2	10319-105A4	84.53	26.98	5.40	3.60	0.00	0.00	1.80	0.00
Urothelial Cells, donor1	11520-119H8	47.02	3.98	11.16	3.98	1.86	0.00	0.00	0.00
Urothelial Cells, donor2	11600-120H7	34.45	1.60	9.61	3.20	0.80	0.00	0.00	0.40
Urothelial Cells, donor3	11681-122H7	29.34	1.38	11.00	1.60	0.23	0.46	0.00	0.00
Urothelial cells, donor0	11216-116B1	77.79	17.83	26.52	7.13	0.89	0.45	0.00	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	137.03	6.23	18.69	8.01	0.00	0.00	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	128.67	11.44	31.45	4.29	5.72	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	86.25	5.48	10.95	6.16	0.68	0.68	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	90.22	4.13	14.46	8.26	0.69	0.00	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	94.71	11.04	18.01	9.88	0.58	0.58	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	99.96	10.41	14.58	11.45	4.16	1.04	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	113.81	7.34	27.53	2.75	5.51	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	82.16	3.65	15.52	4.56	0.91	0.00	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	56.01	29.24	14.56	3.33	1.23	0.00	0.25	0.25
Wilms' tumor cell line:HFWT	10597-108E3	73.04	3.52	14.08	7.04	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	62.01	9.22	19.83	7.26	1.68	0.00	0.56	0.00
achilles tendon, donor2	10292-104G4	49.60	14.47	16.53	8.27	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	45.13	7.39	13.26	8.41	2.29	0.51	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	44.58	9.52	11.84	5.57	1.16	0.00	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	68.26	7.36	16.14	10.21	5.94	0.12	0.12	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	42.45	20.95	14.15	3.81	1.09	0.82	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	170.06	24.17	25.58	19.39	8.71	0.84	0.84	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	75.08	17.76	18.40	5.29	1.69	0.00	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	75.13	9.80	14.16	8.17	3.27	0.54	0.27	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	57.28	11.90	10.58	8.81	0.88	0.44	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	60.85	8.98	8.17	7.76	2.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	96.30	12.04	19.41	10.87	10.48	0.78	1.16	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	16.19	3.13	4.42	0.92	0.74	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	50.71	3.90	27.30	15.60	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	84.82	26.96	19.29	12.32	3.49	0.23	0.23	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	80.26	21.75	16.31	7.77	2.59	0.26	0.52	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	77.44	18.41	22.80	7.60	3.21	0.29	0.29	0.00
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	198.92	17.66	28.35	63.67	14.87	0.00	0.93	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	60.45	10.28	13.57	11.10	5.35	0.41	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	54.64	5.22	15.35	8.90	3.99	0.31	0.61	0.92
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	88.76	27.31	26.88	11.09	4.69	0.00	0.43	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	71.27	32.15	35.18	6.07	2.12	0.91	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	85.45	30.81	30.09	14.20	3.85	0.24	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	62.14	19.16	11.36	10.69	4.23	0.22	0.22	0.22
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	36.36	7.67	8.67	4.67	0.67	0.00	0.00	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	72.47	3.72	14.87	1.86	3.72	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	76.46	23.35	14.31	5.65	5.27	0.38	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	71.96	10.90	10.47	8.72	5.23	0.00	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	80.60	9.37	7.50	3.75	1.87	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	138.47	43.57	34.85	8.48	2.59	0.71	0.47	0.00
adipose tissue, adult, pool1	10010-101C1	99.28	39.71	21.87	16.75	2.79	0.16	0.00	0.00
adipose, donor1	10184-103D4	92.07	12.31	29.91	5.28	4.69	0.59	2.93	1.76
adipose, donor2	10185-103D5	49.47	4.46	12.57	4.06	1.62	2.84	0.81	0.00
adipose, donor3	10186-103D6	57.18	8.44	16.07	4.90	1.63	0.54	0.27	0.27
adipose, donor4	10187-103D7	70.21	10.40	65.87	5.20	0.00	0.87	0.00	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	65.50	27.30	20.67	2.21	0.95	0.47	0.16	0.32
adrenal gland, adult, pool1	10081-102A9	69.12	10.91	29.10	7.28	3.64	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	55.90	5.07	18.14	3.47	0.40	0.40	0.13	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	48.95	27.15	14.65	2.14	0.71	0.00	0.36	0.36
amniotic membrane cells, donor1	12235-129G3	159.98	90.65	39.88	17.16	3.71	0.93	0.23	0.23
amniotic membrane cells, donor2	12236-129G4	105.83	66.94	39.22	10.82	0.68	0.00	0.34	0.68
amniotic membrane cells, donor3	12237-129G5	93.09	105.17	37.41	9.72	0.59	1.18	2.36	0.88
amygdala - adult, donor10196	10167-103B5	170.75	81.82	50.99	11.86	0.00	2.37	3.56	1.19
amygdala, adult, donor10252	10151-102I7	118.01	51.30	21.90	10.75	2.03	0.81	3.24	0.81
amygdala, newborn, donor10223	10360-105E9	91.34	36.80	17.11	14.20	5.81	0.65	1.61	1.29
anaplastic carcinoma cell line:8305C	10428-106D5	91.93	31.07	23.56	3.82	0.25	0.13	0.25	0.13
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	43.68	19.86	10.81	6.62	1.54	0.66	0.66	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	84.51	15.70	18.37	4.34	0.67	0.67	1.00	0.00
aorta, adult, pool1	10052-101G7	88.46	37.46	19.22	4.31	1.37	1.57	0.39	0.39
appendix, adult	10189-103D9	86.16	24.45	21.73	8.54	2.72	0.39	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	82.89	29.23	18.23	6.88	3.44	0.00	0.00	0.00
artery, adult	10190-103E1	78.80	29.89	17.66	5.43	2.72	0.00	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	96.77	26.37	19.85	10.00	1.88	0.87	0.43	0.43
b cell line:RPMI1788	10427-106D4	44.02	9.22	11.90	4.01	1.19	0.00	0.00	0.00
basal cell carcinoma cell line:TE 354.T	10702-109G9	123.19	39.12	22.75	18.59	3.05	0.55	1.11	1.11
bile duct carcinoma cell line:HuCCT1	10432-106D9	77.40	19.25	20.84	7.14	2.18	0.10	0.10	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	92.39	20.75	13.22	6.86	0.33	0.50	0.17	0.33
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	59.84	8.95	12.86	5.59	2.24	0.56	0.00	0.56
bladder, adult, pool1	10011-101C2	90.93	28.68	20.32	4.24	0.65	0.22	0.11	0.33
blood, adult, pool1	10053-101G8	59.79	8.86	8.86	4.43	2.21	0.00	2.21	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	82.21	24.83	15.41	8.56	3.43	0.00	0.00	0.86
bone marrow, adult	10192-103E3	97.85	47.91	18.90	21.59	6.07	0.00	0.67	0.00
brain, adult, donor1	10084-102B3	102.51	35.88	29.73	5.13	0.00	1.03	1.03	2.05
brain, adult, pool1	10012-101C3	138.08	65.59	35.63	6.46	1.34	0.67	0.33	0.33
brain, fetal, pool1	10085-102B4	189.67	26.71	32.06	8.01	2.67	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	60.79	8.26	18.50	2.97	1.65	0.00	0.00	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	97.74	26.46	13.48	7.36	0.75	0.00	0.12	0.00
breast, adult, donor1	10080-102A8	144.58	12.00	13.26	73.24	5.05	0.00	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	41.92	32.90	7.62	3.30	0.76	0.00	0.13	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	81.32	36.49	28.45	4.95	1.55	0.31	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	34.76	28.09	11.51	0.69	0.69	0.69	0.69	0.69
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	42.12	14.77	7.26	4.36	0.73	0.00	0.24	0.00
carcinoid cell line:NCI-H1770	10703-109H1	73.82	12.69	28.68	5.64	0.94	1.41	0.94	0.47
carcinoid cell line:NCI-H727	10735-110B6	152.26	20.56	25.60	24.28	3.83	0.22	0.22	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	47.22	22.82	15.53	5.07	1.90	0.32	0.32	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	69.47	30.61	17.83	3.73	1.33	0.53	0.53	0.53
caudate nucleus - adult, donor10196	10177-103C6	148.52	61.02	33.39	5.76	2.30	0.00	3.45	0.00
caudate nucleus, adult, donor10252	10164-103B2	131.85	61.74	18.41	6.69	1.51	1.34	3.18	1.34
caudate nucleus, adult, donor10258	10379-105H1	147.48	107.74	15.28	5.35	1.53	0.76	2.29	1.53
caudate nucleus, newborn, donor10223	10354-105E3	85.33	30.76	14.65	16.48	2.93	0.00	0.37	0.00
cerebellum - adult, donor10196	10173-103C2	262.19	52.44	49.53	26.22	0.00	0.00	8.74	0.00
cerebellum, adult, donor10252	10166-103B4	166.97	31.17	22.63	7.69	3.63	0.43	0.21	0.21
cerebellum, adult, pool1	10083-102B2	116.59	27.25	25.18	7.93	2.41	1.72	1.38	0.00
cerebellum, newborn, donor10223	10357-105E6	80.54	36.53	18.27	13.28	7.47	0.83	2.49	1.66
cerebral meninges, adult	10188-103D8	157.84	57.49	37.06	8.82	2.27	0.76	2.27	0.50
cerebrospinal fluid, donor2	10294-104G6	54.09	21.93	14.62	5.85	2.19	0.00	0.73	0.00
cervical cancer cell line:D98-AH2	10552-107I3	57.37	27.46	10.64	4.17	0.43	0.29	0.14	0.00
cervical cancer cell line:ME-180	10553-107I4	96.12	20.88	22.54	13.59	3.31	0.00	0.17	0.17
cervix, adult, pool1	10013-101C4	114.96	43.89	21.00	14.07	1.47	0.31	0.00	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	138.92	49.05	28.70	12.26	1.11	0.42	0.42	0.56
chondrosarcoma cell line:SW 1353	10700-109G7	75.76	16.98	14.37	3.92	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	68.10	6.84	19.39	7.71	1.12	0.00	0.12	0.00
choriocarcinoma cell line:SCH	10785-110H2	60.62	10.72	10.97	8.38	1.85	0.49	0.62	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	49.33	6.88	9.96	2.85	0.47	0.24	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	173.80	67.24	35.05	28.78	3.42	1.42	0.85	1.14
chorionic membrane cells, donor2	12239-129G7	99.03	24.56	25.35	10.34	2.78	0.20	0.10	0.00
chorionic membrane cells, donor3	12240-129G8	170.89	49.45	35.17	24.73	8.24	4.40	0.00	2.75
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	31.30	13.13	7.07	12.12	10.10	1.01	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	115.84	22.09	20.17	11.33	3.65	0.19	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	58.08	11.40	16.05	4.65	2.96	0.21	0.42	0.42
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	44.43	4.11	11.04	5.39	1.03	0.00	0.26	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	44.26	6.77	12.82	2.42	0.48	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	47.85	5.09	8.35	3.26	1.22	0.20	0.00	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	50.94	12.66	8.54	2.65	0.88	0.00	0.29	0.00
chronic myelogenous leukemia cell line:KU812	10409-106B4	116.76	20.33	21.11	7.04	0.52	0.00	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	82.98	61.49	27.66	4.34	1.60	0.91	0.69	0.23
clear cell carcinoma cell line:TEN	10636-108I6	100.98	27.41	17.87	11.97	1.74	0.52	0.00	0.17
colon carcinoma cell line:CACO-2	10513-107D9	64.98	21.60	19.04	10.07	3.11	0.00	0.18	0.00
colon carcinoma cell line:COLO-320	10420-106C6	77.92	25.47	26.61	6.46	2.66	0.00	0.00	0.00
colon, adult, donor1	10082-102B1	119.00	10.71	20.23	10.71	3.57	1.19	0.00	0.00
colon, adult, pool1	10014-101C5	105.40	22.80	19.15	9.40	2.82	0.47	0.12	0.35
colon, fetal, donor1	10070-101I7	93.32	17.92	13.60	12.36	1.85	0.62	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	302.51	4.58	59.59	4.58	9.17	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	25.04	0.00	50.07	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	45.47	12.32	4.67	9.77	2.55	0.00	0.42	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	47.69	16.00	6.49	6.49	1.51	0.00	0.00	0.00
cord blood derived cell line:COBL-a untreated	10449-106F8	47.66	16.22	7.19	6.06	1.97	0.14	0.00	0.00
corpus callosum, adult, pool1	10042-101F6	138.20	26.42	34.27	12.83	1.44	0.22	0.44	0.00
cruciate ligament, donor2	10295-104G7	63.22	26.75	13.78	7.29	0.81	1.62	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	97.11	30.50	21.67	7.22	0.00	0.80	1.61	0.00
diencephalon, adult	10193-103E4	113.99	36.00	22.80	10.80	1.44	0.24	0.48	0.48
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	27.09	5.51	6.66	2.76	5.05	0.46	0.00	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	153.86	29.75	31.80	10.26	3.08	0.00	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	107.36	54.40	31.05	7.22	1.20	0.24	0.24	0.48
ductus deferens, adult	10196-103E7	88.70	54.32	15.45	5.48	2.49	1.00	0.00	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	92.17	38.89	14.40	14.40	0.00	1.44	0.00	1.44
duodenum, fetal, donor1, tech_rep2	10071-101I8	94.90	46.35	26.48	5.89	1.47	1.47	1.47	0.00
dura mater, adult, donor1	10041-101F5	99.35	41.79	26.01	5.95	1.82	0.08	0.25	0.25
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	31.31	6.22	4.66	6.88	8.88	0.00	0.22	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	44.85	11.75	9.74	10.32	4.30	0.14	0.43	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	69.06	12.95	11.10	0.00	1.23	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	60.24	20.58	17.56	2.12	0.61	0.61	0.30	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	58.04	16.98	11.73	2.16	0.62	0.00	0.00	0.31
embryonic pancreas cell line:2C6	10603-108E9	82.75	17.08	14.45	1.31	1.31	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	63.02	6.70	17.43	3.69	2.01	0.00	0.34	0.67
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	94.60	33.35	38.78	3.44	0.54	0.54	0.36	0.54
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	64.00	26.21	17.21	8.04	1.93	1.13	0.16	0.64
epidermoid carcinoma cell line:A431	10426-106D3	81.03	18.01	17.56	8.89	2.22	0.11	0.11	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	81.06	20.46	19.03	7.92	2.64	0.33	0.11	0.11
epididymis, adult	10197-103E8	70.75	42.28	18.42	5.65	1.05	0.42	0.84	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	70.61	37.79	25.19	3.02	0.00	0.71	0.71	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	71.96	24.38	20.45	8.65	1.18	0.00	0.00	0.79
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	55.57	19.79	12.32	5.77	1.83	0.26	0.13	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	52.85	18.40	11.12	6.30	2.17	0.20	0.10	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	57.58	20.17	12.88	8.63	1.68	0.34	0.11	0.11
esophagus, adult, pool1	10015-101C6	121.26	38.86	23.47	17.31	3.19	0.11	0.11	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	88.29	53.60	22.67	2.63	0.25	0.00	0.13	0.13
eye - muscle inferior rectus, donor1	10272-104E2	99.00	16.90	12.07	7.24	4.83	0.00	2.41	0.00
eye - muscle lateral, donor2	10298-104H1	69.44	12.63	16.83	6.31	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	47.62	5.95	8.93	2.98	2.98	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	76.82	16.05	10.32	2.29	4.59	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	48.09	4.37	10.20	1.46	1.46	0.00	0.00	1.46
eye, fetal, donor1	10054-101G9	83.64	40.93	20.08	4.83	2.29	0.00	0.51	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	51.55	21.41	11.54	2.82	1.15	0.26	0.38	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	75.02	16.86	27.54	6.17	0.71	0.00	0.47	0.00
frontal lobe, adult, pool1	10040-101F4	172.54	88.01	46.82	11.54	1.60	0.28	0.09	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	133.91	31.53	32.43	11.41	2.40	0.60	0.90	0.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	129.84	34.84	35.11	5.76	0.64	0.18	0.09	0.18
gall bladder, adult	10198-103E9	82.57	30.90	19.31	6.04	1.69	0.24	0.24	0.24
gamma delta positive T cells, donor1	11937-126A2	89.65	11.81	11.81	6.98	5.91	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	98.60	13.45	11.58	11.95	13.07	0.00	0.75	0.75
gastric adenocarcinoma cell line:MKN1	10614-108G2	59.14	12.04	15.84	6.34	0.84	0.21	0.21	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	33.65	12.19	7.35	1.55	0.39	0.00	0.39	0.19
gastric cancer cell line:AZ521	10549-107H9	72.14	31.48	26.40	5.25	1.15	0.00	0.16	0.16
gastric cancer cell line:GSS	10560-108A2	58.57	27.46	13.73	0.00	0.92	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	83.62	12.57	15.54	35.41	9.37	0.46	0.23	0.00
giant cell carcinoma cell line:LU65	10487-107B1	73.55	7.00	13.08	3.90	0.69	0.00	0.23	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	65.36	23.65	21.69	2.66	0.42	0.00	0.00	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	69.09	27.19	17.46	4.74	1.75	0.25	0.00	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	50.03	19.10	15.62	4.54	0.74	0.11	0.21	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	54.35	19.52	14.89	3.93	1.26	0.42	0.00	0.42
glioblastoma cell line:T98G	10485-107A8	87.42	53.31	24.94	7.95	2.21	0.33	0.44	0.33
glioma cell line:GI-1	10413-106B8	107.49	31.05	31.34	9.66	2.64	0.00	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	124.64	34.99	20.41	15.31	0.73	0.00	5.83	0.73
globus pallidus, adult, donor10252	10161-103A8	127.17	28.56	19.53	11.96	0.73	0.49	1.95	0.00
globus pallidus, adult, donor10258	10367-105F7	49.29	34.23	9.58	8.22	2.74	0.00	2.74	1.37
globus pallidus, newborn, donor10223	10364-105F4	72.48	18.65	15.99	17.59	4.26	0.53	1.60	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	256.95	12.24	68.52	12.24	22.02	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	10.93	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	47.04	5.23	15.68	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	58.24	22.40	14.72	3.84	2.24	0.64	0.64	0.64
hIPS +CCl2, biol_rep1	14383-156B9	39.94	9.18	17.91	4.13	1.84	0.92	0.00	0.46
hIPS +CCl2, biol_rep2	14384-156C1	42.98	10.97	16.46	7.32	3.20	0.00	0.46	0.46
hIPS +CCl2, biol_rep3	14385-156C2	41.22	10.95	15.46	12.88	3.86	0.00	0.00	0.00
hIPS, biol_rep1	14380-156B6	21.56	8.62	4.31	8.62	7.19	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	47.32	7.54	10.97	4.12	2.06	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	141.24	45.24	33.10	9.93	5.52	1.10	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	33.91	3.45	6.61	1.72	0.57	0.00	0.00	0.00
heart - mitral valve, adult	10205-103F7	84.61	46.04	12.26	6.58	0.90	0.30	0.60	0.30
heart - pulmonic valve, adult	10206-103F8	94.65	48.11	20.66	6.80	1.31	0.26	0.52	1.05
heart - tricuspid valve, adult	10207-103F9	74.11	24.98	11.66	14.15	0.83	0.00	1.67	1.67
heart, adult, diseased post-infarction, donor1	10050-101G5	81.01	43.46	23.06	5.92	0.82	1.22	0.61	0.00
heart, adult, diseased, donor1	10051-101G6	85.59	28.96	19.59	5.54	0.43	1.28	0.00	0.00
heart, adult, pool1	10016-101C7	169.72	24.61	37.49	13.34	2.76	0.23	0.69	0.69
heart, fetal, pool1	10046-101G1	159.46	36.04	30.60	12.63	2.26	0.10	0.00	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	92.87	48.44	25.61	15.12	1.23	0.00	0.00	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	63.03	5.95	16.65	20.22	5.95	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	47.73	16.02	12.27	5.86	1.99	0.33	0.00	0.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	49.04	17.96	12.50	5.58	2.31	0.12	0.12	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	51.23	19.71	11.72	5.25	1.72	0.20	0.10	0.10
hepatoma cell line:Li-7	10484-107A7	74.18	6.01	14.79	5.23	1.22	0.22	0.22	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	41.91	8.34	14.07	4.72	1.61	0.00	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	137.22	78.55	30.28	16.09	0.00	1.89	7.57	0.95
hippocampus, adult, donor10252	10153-102I9	114.91	37.76	19.59	10.41	3.06	1.22	2.25	1.43
hippocampus, adult, donor10258	10374-105G5	94.61	67.22	20.42	8.47	1.99	0.50	3.49	1.00
hippocampus, newborn, donor10223	10363-105F3	70.85	26.79	18.33	9.16	3.17	0.35	2.47	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	79.96	14.65	23.19	4.88	3.05	0.00	1.83	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	49.09	6.09	12.76	5.11	2.55	0.39	0.39	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	50.27	8.12	16.76	4.06	2.03	0.51	0.51	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	33.83	4.51	12.41	2.26	0.56	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	43.38	5.42	8.78	2.58	1.55	0.77	1.55	1.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	45.93	6.45	9.87	3.04	2.28	0.38	0.00	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	39.71	5.84	9.93	4.09	2.63	0.58	1.17	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	48.90	6.68	11.20	4.52	1.08	0.43	0.43	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	39.62	6.67	11.68	5.84	1.67	0.42	0.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	79.80	13.73	13.02	7.58	4.74	0.71	0.95	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	64.61	10.45	13.34	8.52	1.93	0.48	0.48	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	78.10	18.85	18.18	10.10	1.35	1.35	0.67	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	46.79	6.73	11.27	3.13	1.10	0.63	0.47	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	50.60	7.86	7.86	1.47	2.95	0.49	0.49	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	41.02	13.09	13.09	6.11	3.49	0.87	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	50.21	4.39	14.32	5.35	1.15	0.19	0.57	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	46.22	6.11	19.19	2.18	1.74	0.00	0.44	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	43.98	4.50	13.99	3.00	3.50	1.50	1.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	45.59	5.46	12.06	2.26	1.13	0.38	0.00	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	50.47	2.73	10.91	4.09	0.91	0.45	0.91	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	47.93	5.95	9.71	2.82	2.19	0.63	0.31	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	66.14	11.76	12.41	3.92	1.31	1.31	0.65	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	63.29	13.06	11.90	5.52	2.32	0.29	0.58	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	46.63	8.07	14.35	7.17	2.39	1.79	1.20	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	47.85	7.57	13.30	5.36	2.59	0.00	0.37	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	48.50	7.42	14.83	3.99	2.57	0.00	0.57	0.86
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	64.51	17.56	17.56	9.39	4.08	0.00	0.41	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	44.36	4.93	16.20	5.28	0.35	0.35	1.41	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	39.91	3.17	9.50	4.43	3.17	0.32	0.32	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	42.37	4.24	14.83	1.51	1.82	0.30	0.00	0.91
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	48.61	6.72	8.79	2.59	2.07	0.00	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	48.48	9.96	11.29	5.31	0.00	0.00	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	35.66	7.18	10.77	2.31	2.05	0.77	0.51	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	63.91	15.34	8.18	7.41	2.05	1.02	1.53	0.51
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	65.88	11.36	11.36	6.82	3.79	0.00	0.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	48.73	15.46	10.08	7.06	2.69	0.34	1.68	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	53.61	6.28	10.87	5.07	0.97	0.00	0.00	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	52.59	8.02	17.38	7.13	3.57	0.45	0.45	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	39.02	7.32	11.71	5.37	0.49	0.49	0.98	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	44.31	2.14	10.70	3.97	1.53	0.00	0.92	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	156.16	48.80	45.55	3.25	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	49.64	4.30	15.22	3.97	0.99	0.66	0.99	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	45.97	4.38	8.21	3.83	1.64	0.00	0.55	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	47.41	5.07	10.86	4.34	1.81	0.00	1.81	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	38.08	2.85	13.17	1.78	0.71	0.36	0.36	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	46.54	10.74	7.16	2.39	2.39	1.19	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	84.37	11.24	16.52	7.31	2.44	0.27	0.27	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	40.95	10.24	8.62	4.04	0.27	0.27	0.54	0.00
immature langerhans cells, donor1	11904-125F5	64.41	22.52	20.58	10.90	2.66	0.48	0.00	0.24
immature langerhans cells, donor2	11905-125F6	44.36	19.01	19.01	8.71	2.38	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	174.60	82.05	49.40	11.55	2.65	0.19	0.00	0.19
keratoacanthoma cell line:HKA-1	10791-110H8	51.05	21.46	11.38	6.50	2.60	0.00	0.00	0.33
kidney, adult, pool1	10017-101C8	110.04	46.76	24.73	6.91	1.20	0.20	0.00	0.40
kidney, fetal, pool1	10045-101F9	99.53	16.20	22.49	7.29	1.27	0.07	0.00	0.07
large cell lung carcinoma cell line:IA-LM	10509-107D5	111.34	33.52	22.01	8.38	1.70	0.00	0.00	0.00
large cell lung carcinoma cell line:NCI-H460	10839-111E2	34.28	8.29	7.05	1.66	0.55	0.41	0.14	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	85.33	8.81	22.20	5.87	0.73	0.00	0.18	0.18
left atrium, adult, donor1	10079-102A7	57.21	41.95	13.62	3.81	1.09	1.09	2.72	1.09
left ventricle, adult, donor1	10078-102A6	101.64	42.98	14.66	2.53	1.52	0.00	0.51	0.51
leiomyoblastoma cell line:G-402	10721-110A1	48.70	29.00	14.50	3.28	0.82	0.00	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	44.55	34.85	7.54	5.39	1.80	1.44	0.00	0.00
leiomyoma cell line:15242A	10570-108B3	53.26	29.89	10.87	9.24	3.26	1.09	1.63	0.54
leiomyoma cell line:15425	10571-108B4	45.89	37.15	11.90	3.64	0.00	0.49	0.00	0.24
leiomyosarcoma cell line:Hs 5.T	10722-110A2	146.04	31.75	25.40	25.40	6.35	0.00	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	60.64	5.23	18.82	7.32	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	57.38	20.31	10.63	5.55	1.18	0.00	0.00	0.00
liposarcoma cell line:KMLS-1	10782-110G8	85.29	64.67	22.65	11.56	2.03	0.31	0.00	0.31
liposarcoma cell line:SW 872	10726-110A6	61.53	16.20	15.11	7.31	3.66	0.12	0.37	0.12
liver, adult, pool1	10018-101C9	105.50	64.34	25.61	8.10	1.13	0.32	0.00	0.16
liver, fetal, pool1	10086-102B5	56.44	14.11	17.87	10.35	0.94	0.00	0.94	0.94
locus coeruleus - adult, donor10196	10182-103D2	110.97	25.52	18.23	9.62	3.79	0.29	5.10	0.29
locus coeruleus, adult, donor10252	10165-103B3	111.10	28.24	19.38	11.26	2.03	0.55	0.74	1.11
locus coeruleus, adult, donor10258	10375-105G6	86.62	40.06	17.77	9.87	3.10	0.00	0.85	0.56
locus coeruleus, newborn, donor10223	10362-105F2	79.50	38.70	14.30	13.46	2.94	1.26	3.36	1.26
lung adenocarcinoma cell line:A549	10499-107C4	66.29	32.38	27.40	2.63	1.11	0.14	0.28	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	42.05	8.96	12.41	2.07	0.69	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	99.26	37.83	30.98	4.48	1.71	0.00	0.40	0.66
lung, adult, pool1	10019-101D1	105.72	25.40	20.20	7.44	0.59	0.12	0.12	0.35
lung, fetal, donor1	10068-101I5	158.12	72.78	32.25	17.41	1.71	0.00	0.29	0.29
lung, right lower lobe, adult, donor1	10075-102A3	98.97	32.99	24.29	8.25	0.92	0.00	1.83	0.00
lymph node, adult, donor1	10077-102A5	50.65	17.04	8.52	2.84	0.47	0.00	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	48.88	15.56	11.40	5.48	1.75	0.22	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	25.96	5.28	5.13	4.68	3.32	0.15	0.15	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	114.68	27.18	17.84	13.59	2.55	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	265.95	59.05	66.15	84.80	15.10	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	226.41	56.45	53.33	73.88	7.06	0.42	0.21	0.42
mature adipocyte, donor3	12233-129G1	156.22	70.17	38.88	36.03	7.35	0.24	0.24	0.24
mature adipocyte, donor4	12234-129G2	152.40	62.65	35.53	44.48	5.79	0.00	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	131.76	31.21	25.97	7.62	2.14	0.00	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	172.59	86.86	32.71	14.66	2.26	1.13	2.26	1.13
medial frontal gyrus, adult, donor10252	10150-102I6	128.55	52.05	20.78	10.30	3.13	0.37	2.39	0.74
medial frontal gyrus, adult, donor10258	10368-105F8	130.57	67.67	32.72	5.72	1.59	1.59	1.59	1.27
medial frontal gyrus, newborn, donor10223	10352-105E1	138.61	100.22	26.44	12.37	5.54	0.85	0.43	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	173.14	109.18	30.54	12.15	1.52	5.74	3.54	4.73
medial temporal gyrus, adult, donor10252	10156-103A3	124.36	49.24	21.01	11.46	1.49	0.64	5.73	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	78.98	82.83	17.34	15.41	1.93	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	272.72	229.66	14.35	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	103.01	38.41	21.89	15.79	3.23	0.36	0.72	0.72
medulla oblongata - adult, donor10196	10174-103C3	111.62	32.45	20.12	14.28	1.95	1.30	0.65	0.65
medulla oblongata, adult, donor10252	10155-103A2	105.42	28.79	15.79	9.29	0.93	0.46	0.46	0.15
medulla oblongata, adult, pool1	10038-101F2	125.38	34.69	34.37	9.88	2.04	0.08	0.08	0.00
medulla oblongata, newborn, donor10223	10361-105F1	72.21	14.23	10.76	12.50	1.39	0.69	1.04	0.69
medulloblastoma cell line:D283 Med	10838-111E1	56.46	14.39	15.72	5.09	1.77	0.00	0.00	0.22
medulloblastoma cell line:ONS-76	10759-110E3	63.22	10.76	12.72	5.99	1.47	0.12	0.24	0.12
melanoma cell line:COLO 679	10514-107E1	70.15	20.84	13.08	11.07	2.30	0.14	0.43	0.29
melanoma cell line:G-361	10465-106H6	82.25	32.85	13.84	7.33	0.81	0.54	0.00	0.00
meningioma cell line:HKBMM	10691-109F7	99.14	26.05	19.18	7.42	1.09	1.27	0.54	0.72
merkel cell carcinoma cell line:MKL-1	10843-111E6	90.76	13.22	20.27	14.10	1.76	1.76	0.88	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	147.50	12.70	28.26	22.29	8.30	0.78	0.00	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	101.42	81.17	28.08	7.52	1.23	1.38	0.61	0.92
mesenchymal precursor cell - adipose, donor2	11748-123G2	78.35	38.90	17.09	8.00	0.36	0.91	0.36	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	64.60	36.44	13.67	6.21	0.83	0.00	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	74.59	49.87	20.51	6.60	0.84	0.84	0.28	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	68.17	41.59	17.14	6.35	0.77	0.96	0.96	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	54.14	47.20	18.74	6.25	2.08	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	59.73	27.80	20.42	2.40	1.72	0.17	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	65.90	35.42	19.44	6.10	0.69	0.81	0.12	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	73.22	38.86	21.49	6.23	0.66	0.53	0.40	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	80.35	39.84	19.31	7.83	1.22	0.95	0.27	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	85.64	27.31	23.19	10.24	1.14	0.71	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	46.44	23.38	14.16	5.27	1.65	0.33	0.00	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	75.41	32.10	20.76	5.12	1.25	0.55	0.14	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	57.95	36.30	18.50	6.63	0.70	0.35	0.00	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	72.68	40.02	22.46	8.37	2.45	1.02	1.02	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	58.95	16.89	16.89	7.19	3.59	0.36	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	45.41	43.86	16.24	3.31	0.52	0.52	0.00	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	55.40	20.06	15.73	10.26	4.10	0.46	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	83.49	45.73	22.24	10.91	1.68	0.84	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	84.28	32.13	20.47	8.22	1.64	0.60	0.45	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	69.41	22.76	16.81	6.83	0.79	0.44	0.44	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	55.59	23.56	17.67	3.68	1.10	0.00	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	61.81	15.74	14.02	5.72	0.86	0.29	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	74.52	21.05	16.84	8.42	1.68	2.11	0.42	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	75.81	49.78	22.83	4.57	0.91	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	70.34	44.51	15.09	7.42	0.26	0.77	0.51	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	75.12	45.28	15.71	5.50	0.79	0.79	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	71.17	39.13	16.02	3.39	0.92	0.00	0.62	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	72.25	43.31	16.95	6.12	1.18	1.88	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	76.15	44.00	18.28	6.77	1.35	0.00	0.68	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	69.95	43.62	19.65	9.43	0.00	1.57	0.39	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	65.80	38.46	8.34	7.88	0.46	0.46	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	193.21	0.00	48.30	0.00	0.00	0.00	0.00	48.30
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	85.66	51.05	24.52	6.63	1.44	0.58	0.87	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	76.52	42.61	15.62	7.59	1.34	1.34	0.45	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	68.98	42.30	16.82	5.29	0.24	0.96	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	104.87	50.60	22.00	9.53	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	70.15	39.27	13.09	9.40	1.34	0.00	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	72.05	30.29	13.51	4.91	1.23	0.82	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	64.43	45.53	14.18	8.59	3.01	1.72	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	71.09	41.02	13.67	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	56.81	30.99	30.99	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	78.92	44.50	18.19	8.77	1.62	0.32	0.65	0.65
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	66.93	42.19	33.46	8.73	2.91	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	82.09	37.32	19.72	12.26	2.13	0.53	0.00	2.13
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	75.23	34.35	10.63	7.36	1.64	1.64	2.45	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	75.41	33.43	18.66	7.00	1.94	0.78	0.78	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	62.96	27.28	10.49	4.20	4.20	4.20	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	76.50	22.85	12.92	12.92	0.00	1.99	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	76.28	52.44	19.07	4.77	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	64.04	39.73	13.64	9.49	2.37	0.59	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	68.23	36.55	15.84	2.44	1.22	0.00	3.66	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	54.10	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	67.77	45.60	13.30	8.23	1.90	0.63	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	69.33	45.53	9.31	4.83	1.72	0.69	1.03	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	47.28	47.28	10.75	6.45	2.15	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	43.91	15.97	15.97	0.00	0.00	0.00	0.00	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	55.10	41.33	6.89	3.44	0.00	3.44	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	47.67	39.52	11.82	5.70	0.41	0.41	1.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	58.79	47.67	7.15	1.59	1.59	0.79	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	47.16	34.78	11.79	5.31	1.18	0.00	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	48.31	52.05	12.47	6.86	0.62	0.31	0.62	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	57.48	33.42	9.36	5.35	0.00	2.67	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	63.86	41.39	18.92	14.19	3.55	3.55	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	87.31	43.66	5.14	12.84	2.57	2.57	5.14	5.14
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	63.33	46.12	18.59	13.08	1.38	0.69	0.69	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	93.02	47.50	19.79	16.33	5.44	0.99	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	69.53	37.01	19.07	20.19	1.12	0.00	2.24	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	80.14	38.80	22.26	19.72	3.18	1.91	0.64	0.64
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	83.42	31.84	20.96	26.60	6.45	0.00	1.21	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	91.58	28.35	26.17	23.99	4.36	2.18	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	77.29	15.20	19.01	16.47	5.07	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	100.74	37.63	27.92	20.63	2.43	0.00	0.61	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	135.57	31.63	40.67	22.59	9.04	0.00	9.04	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	102.14	29.65	23.06	18.94	8.24	4.12	0.00	0.82
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	73.81	38.89	14.49	14.49	1.59	0.40	0.60	0.99
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	58.41	39.91	13.30	12.33	0.97	0.00	0.65	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	60.10	32.60	17.32	18.34	0.00	1.02	2.04	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	104.45	23.21	17.80	8.51	2.32	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	105.36	21.73	47.48	5.20	1.42	0.24	0.24	0.47
mesothelioma cell line:ACC-MESO-4	10494-107B8	112.83	44.71	23.17	19.23	2.32	0.46	0.70	0.00
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	34.19	29.92	17.09	38.46	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	69.56	39.66	14.28	11.30	2.98	0.21	0.00	0.72
mesothelioma cell line:Mero-25	10850-111F4	51.75	4.99	7.49	7.04	2.04	0.00	0.00	0.00
mesothelioma cell line:Mero-41	10851-111F5	60.87	24.69	12.71	6.11	0.49	1.22	0.24	0.24
mesothelioma cell line:Mero-48a	10852-111F6	65.32	29.89	14.61	8.64	2.44	0.66	0.66	0.22
mesothelioma cell line:Mero-82	10853-111F7	54.93	14.19	8.67	4.73	1.58	0.26	0.79	0.79
mesothelioma cell line:Mero-83	10854-111F8	66.39	30.47	16.00	9.02	2.55	0.85	0.00	0.34
mesothelioma cell line:Mero-84	10855-111F9	48.03	33.62	15.67	4.55	1.01	0.25	0.76	0.00
mesothelioma cell line:Mero-95	10856-111G1	67.70	39.96	16.36	8.28	1.66	0.21	0.41	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	79.18	36.61	25.34	10.60	4.64	0.17	0.33	0.17
mesothelioma cell line:NCI-H226	10846-111E9	57.74	31.31	13.57	11.58	5.97	0.90	0.36	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	29.21	19.64	9.05	1.88	1.20	0.17	0.17	0.17
mesothelioma cell line:NCI-H28	10845-111E8	50.89	29.77	17.30	4.58	0.00	0.25	0.00	0.25
mesothelioma cell line:No36	10857-111G2	41.75	13.05	7.18	4.89	1.30	0.65	0.98	0.00
mesothelioma cell line:ONE58	10858-111G3	52.56	8.40	10.03	7.04	2.44	0.00	0.27	0.54
migratory langerhans cells, donor1	11901-125F2	41.46	19.19	10.36	2.88	0.58	0.00	0.00	0.19
migratory langerhans cells, donor2	11902-125F3	51.65	15.14	17.95	3.66	0.49	0.00	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	51.69	16.87	15.79	4.13	1.26	0.00	0.00	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	107.09	13.06	18.28	7.84	1.63	1.96	1.31	0.00
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	78.42	8.69	20.98	5.93	0.64	0.42	0.64	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	84.31	14.28	13.36	7.83	1.15	0.00	0.00	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	27.40	8.94	7.80	2.66	0.95	0.00	0.38	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	99.60	9.98	20.33	7.21	0.37	0.55	0.18	0.00
myeloma cell line:PCM6	10474-106I6	48.82	16.60	14.83	1.19	0.20	0.40	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	41.60	30.44	14.20	4.57	0.51	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	94.34	40.21	15.69	5.69	0.98	0.39	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	79.56	17.49	20.72	4.23	0.45	0.00	0.11	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	73.54	18.61	17.13	3.75	0.74	0.22	0.15	0.07
nasal epithelial cells, donor2	12227-129F4	102.67	27.60	29.81	6.62	1.10	0.55	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	73.16	9.66	19.79	5.52	1.38	0.46	0.00	0.23
neuroblastoma cell line:NB-1	10539-107G8	81.38	18.33	20.77	5.43	1.68	0.37	0.19	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	52.09	5.69	9.91	4.22	3.37	0.21	0.00	0.21
neuroblastoma cell line:NH-12	10555-107I6	57.58	10.81	14.16	3.73	5.03	0.19	0.00	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	34.40	5.46	9.73	3.08	0.71	0.00	0.24	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	84.89	27.87	17.26	8.08	3.17	0.48	0.32	0.16
neuroectodermal tumor cell line:TASK1	10774-110F9	34.42	14.89	10.26	2.42	0.40	0.40	0.00	0.60
neuroepithelioma cell line:SK-N-MC	10728-110A8	112.53	15.89	31.15	8.90	8.26	0.00	0.00	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	86.50	36.46	16.50	8.52	1.60	0.00	0.80	0.27
neutrophil PMN, donor1	12133-128D9	758.62	0.00	178.50	29.75	29.75	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	292.17	0.00	13.28	39.84	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	208.35	0.00	0.00	9.47	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	114.33	4.57	15.73	7.95	1.69	0.00	0.17	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	177.71	20.01	35.22	36.02	12.81	0.80	0.80	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	78.55	56.75	18.60	5.77	0.96	2.89	1.92	1.92
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	66.74	25.23	10.25	7.36	1.58	0.26	0.26	0.53
nucleus accumbens, adult, pool1	10037-101F1	152.42	76.87	43.12	10.59	1.78	0.37	0.47	0.47
occipital cortex - adult, donor10196	10172-103C1	203.98	119.50	63.87	8.24	0.00	2.06	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	122.64	39.45	21.47	8.86	1.34	1.34	1.88	0.54
occipital cortex, newborn, donor10223	10355-105E4	95.35	31.30	19.65	16.74	3.28	0.00	0.36	0.73
occipital lobe, adult, donor1	10076-102A4	174.76	59.83	34.90	9.71	4.46	0.52	4.72	1.05
occipital lobe, fetal, donor1	10073-102A1	249.31	27.89	38.19	13.73	4.29	1.29	5.58	0.00
occipital pole, adult, pool1	10036-101E9	121.42	33.51	38.08	8.12	0.71	0.08	0.08	0.08
olfactory region, adult	10195-103E6	123.23	52.54	23.69	9.17	1.91	0.38	2.29	0.57
optic nerve, donor1	10277-104E7	162.08	16.01	26.01	14.01	4.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	69.14	23.69	15.95	9.91	2.28	0.00	0.23	0.00
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	76.11	12.50	25.69	3.30	0.55	0.00	0.00	0.00
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	60.79	32.00	15.41	5.08	1.86	0.17	0.00	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	90.67	33.04	17.79	6.93	2.31	0.12	0.12	0.12
osteoclastoma cell line:Hs 706.T	10704-109H2	92.89	29.98	24.69	9.99	1.76	0.88	0.59	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	172.85	22.42	40.18	14.02	1.87	0.00	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	77.83	24.60	14.42	15.48	2.97	0.21	0.21	0.21
ovary, adult, pool1	10020-101D2	79.84	23.85	19.30	3.58	0.35	0.00	0.09	0.09
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	75.71	12.47	22.00	7.15	2.20	0.55	0.37	0.55
pancreas, adult, donor1	10049-101G4	92.18	47.03	23.52	5.64	0.00	0.94	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	88.61	16.49	20.41	13.14	2.80	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	81.43	20.44	17.89	6.64	2.38	0.68	0.51	0.00
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	83.29	11.92	16.56	9.11	0.99	0.33	0.00	0.00
paracentral gyrus, adult, pool1	10035-101E8	160.44	64.25	48.78	11.35	1.74	0.27	0.18	0.09
parietal cortex, adult, donor10258	10373-105G4	107.90	57.99	45.51	6.61	1.47	1.47	2.20	0.00
parietal lobe - adult, donor10196	10171-103B9	128.85	80.88	32.92	11.29	0.00	1.88	5.64	0.00
parietal lobe, adult, donor10252	10157-103A4	119.15	51.59	20.81	9.12	1.43	0.29	1.71	0.86
parietal lobe, adult, pool1	10034-101E7	147.51	60.27	44.50	9.87	1.06	0.09	0.09	0.09
parietal lobe, fetal, donor1	10072-101I9	189.12	31.03	45.58	14.55	9.70	0.97	0.97	0.00
parietal lobe, newborn, donor10223	10356-105E5	111.04	35.52	23.55	13.46	6.73	1.12	0.75	1.12
parotid gland, adult	10199-103F1	134.43	56.12	35.77	8.63	1.85	0.62	0.00	0.62
penis, adult	10200-103F2	72.51	37.06	16.65	3.76	2.15	1.07	0.00	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	66.19	33.10	12.83	3.16	1.12	0.19	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	47.06	13.11	13.11	4.08	1.17	0.00	0.00	0.58
pineal gland - adult, donor10196	10179-103C8	116.10	28.38	20.64	5.16	1.29	1.29	5.81	0.00
pineal gland, adult, donor10252	10160-103A7	131.47	29.61	23.10	4.15	0.00	0.00	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	75.25	28.85	11.91	4.39	1.25	0.63	2.51	0.00
pituitary gland - adult, donor10196	10180-103C9	188.19	101.18	62.73	15.18	2.02	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	203.78	134.99	61.50	8.86	0.52	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	108.11	117.47	19.58	10.21	1.70	0.85	0.85	0.00
placenta, adult, pool1	10021-101D3	165.12	42.14	33.76	16.13	2.69	0.11	0.75	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	46.75	7.55	9.80	5.56	1.99	0.00	0.00	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	72.22	26.61	14.16	7.94	1.25	0.31	0.47	0.31
pons, adult, pool1	10033-101E6	139.08	38.64	46.39	12.22	3.27	0.34	0.26	0.09
postcentral gyrus, adult, pool1	10032-101E5	135.91	50.56	40.10	8.63	1.66	0.26	0.26	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	345.08	2.09	75.29	52.28	12.55	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	71.60	5.51	11.02	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	58.68	0.00	23.47	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	77.35	25.35	28.40	3.93	1.02	0.58	0.00	0.15
prostate cancer cell line:PC-3	10439-106E7	59.17	14.16	14.70	3.81	0.73	0.00	0.18	0.18
prostate, adult, pool1	10022-101D4	80.08	34.55	19.77	4.63	1.09	0.18	0.18	0.00
putamen, adult, donor10196	10176-103C5	168.79	113.78	37.06	10.39	2.36	1.18	2.36	0.94
putamen, adult, donor10252	10152-102I8	125.49	37.25	23.53	17.65	5.88	0.00	9.80	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	59.01	50.27	16.39	2.19	1.09	1.09	3.28	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	133.61	67.65	32.62	8.94	1.21	0.48	1.21	0.24
putamen, newborn, donor10223	10365-105F5	76.47	71.97	11.24	14.99	4.50	0.00	0.75	0.00
rectal cancer cell line:TT1TKB	10469-106I1	190.85	20.07	44.51	31.42	4.95	0.00	0.00	0.58
rectum, fetal, donor1	10067-101I4	133.54	34.77	22.26	9.74	1.39	0.00	0.00	2.78
renal cell carcinoma cell line:OS-RC-2	10411-106B6	48.34	36.68	16.96	5.30	2.54	0.00	0.00	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	49.29	26.92	26.51	1.66	0.00	0.83	0.00	0.00
retina, adult, pool1	10030-101E3	81.41	29.02	19.98	3.58	0.50	0.10	0.20	0.10
retinoblastoma cell line:Y79	10475-106I7	36.63	5.46	12.99	1.30	0.00	0.26	0.00	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	57.05	33.81	14.88	3.32	0.49	0.37	0.12	0.49
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	119.79	21.93	35.99	12.94	3.66	0.00	0.56	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	96.25	25.77	21.22	3.79	3.79	0.00	0.76	0.76
salivary acinar cells, donor1	11771-123I7	41.60	28.49	11.01	3.40	0.65	0.32	0.16	0.16
salivary acinar cells, donor2	11772-123I8	48.47	34.97	13.08	3.86	0.28	0.00	0.28	0.28
salivary acinar cells, donor3	11773-123I9	74.15	19.20	18.54	9.93	1.99	0.00	0.66	0.00
salivary gland, adult, pool1	10093-102C3	112.67	56.05	28.03	12.01	1.72	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	69.81	14.25	15.93	4.05	1.01	0.17	0.17	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	83.34	12.46	18.10	5.05	0.82	0.12	0.35	0.35
seminal vesicle, adult	10201-103F3	88.35	44.44	24.34	5.82	1.59	0.53	1.59	1.59
serous adenocarcinoma cell line:JHOS-2	10639-108I9	48.58	51.74	16.28	4.62	1.70	0.49	0.49	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	54.10	13.08	20.13	5.28	2.01	0.25	0.00	0.25
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	67.24	18.06	14.05	5.02	3.01	1.00	1.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	101.41	12.76	20.42	17.86	3.22	0.94	0.94	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	90.63	11.27	14.26	10.61	3.87	0.00	0.00	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	55.22	23.87	12.77	6.84	2.32	0.26	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	100.02	36.89	14.19	12.77	2.13	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	172.11	42.34	34.54	24.59	5.04	0.24	0.00	0.24
skeletal muscle, fetal, donor1	10066-101I3	60.30	22.11	3.02	4.02	0.00	0.00	1.01	0.00
skin, adult, donor1	10074-102A2	101.78	40.71	6.79	20.36	6.79	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	92.16	62.49	16.41	8.84	2.52	0.63	1.26	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	111.40	14.68	17.34	41.02	20.68	0.33	1.00	0.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	150.98	48.23	29.00	21.43	3.78	1.26	0.63	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	95.02	27.56	37.20	4.43	0.58	0.58	0.19	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	123.46	15.82	14.01	14.01	7.09	0.16	0.33	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	53.72	3.54	19.78	2.41	0.32	0.00	0.00	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	97.84	12.86	15.91	11.33	4.58	0.22	0.65	0.87
small intestine, adult, pool1	10024-101D6	154.44	29.26	27.11	14.45	2.63	0.12	0.00	0.24
small intestine, fetal, donor1	10064-101I1	90.91	27.76	17.94	6.88	0.98	1.23	0.49	0.00
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	165.67	29.75	11.28	49.24	14.87	3.08	0.51	1.03
smooth muscle, adult, pool1	10048-101G3	86.32	45.75	18.35	3.10	0.26	0.78	1.03	0.00
somatostatinoma cell line:QGP-1	10781-110G7	62.72	8.04	8.04	5.09	0.80	0.00	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	116.77	39.23	12.85	10.09	1.38	0.69	0.46	0.92
spinal cord, adult, donor10252	10159-103A6	123.41	28.78	18.92	9.86	2.37	0.00	0.39	0.79
spinal cord, adult, donor10258	10369-105F9	76.10	65.03	17.29	11.76	2.77	0.00	1.38	0.69
spinal cord, fetal, donor1	10056-101H2	165.88	31.10	34.15	17.08	7.93	1.83	3.05	0.00
spinal cord, newborn, donor10223	10359-105E8	112.05	30.31	22.96	13.32	3.67	0.46	0.00	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	99.47	33.75	19.42	11.65	2.39	0.60	0.30	0.15
spleen, adult, pool1	10025-101D7	72.36	14.87	14.87	3.96	1.54	0.00	0.33	0.33
spleen, fetal, pool1	10044-101F8	80.33	10.41	16.29	6.99	1.19	0.00	0.00	0.00
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	38.09	15.94	12.52	3.52	1.24	0.31	0.00	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	38.73	8.73	7.78	2.47	0.57	0.00	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	95.40	82.82	35.29	7.34	2.80	1.75	0.70	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	92.26	16.42	14.46	8.99	2.74	0.00	0.00	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	170.19	26.11	35.01	15.76	2.81	0.68	0.56	0.23
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	31.77	19.91	5.51	4.24	0.85	0.42	0.00	0.85
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	70.23	24.96	15.65	6.35	1.69	0.00	0.00	0.85
stomach, fetal, donor1	10062-101H8	130.29	34.18	20.29	6.41	2.14	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	98.55	34.18	21.08	10.82	2.28	0.57	0.00	0.57
substantia nigra - adult, donor10196	10178-103C7	108.55	54.27	0.00	54.27	0.00	54.27	271.37	54.27
substantia nigra, adult, donor10252	10158-103A5	109.67	20.98	17.66	11.63	0.83	0.62	0.21	0.62
substantia nigra, adult, donor10258	10371-105G2	83.79	46.04	28.45	15.00	1.03	0.00	2.59	1.03
substantia nigra, newborn, donor10223	10358-105E7	91.15	13.42	11.31	30.38	6.36	1.41	2.83	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	146.27	51.58	35.08	23.39	8.94	1.38	0.69	0.69
temporal lobe, adult, pool1	10031-101E4	124.02	37.30	40.61	9.07	1.10	0.25	0.00	0.17
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	198.72	27.78	48.43	8.55	1.42	0.00	2.14	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	169.66	18.46	42.64	7.91	1.76	0.00	1.32	0.88
tenocyte, donor1	11763-123H8	84.83	47.48	21.30	9.08	1.40	0.00	1.05	0.70
tenocyte, donor2	11765-123I1	60.66	44.25	12.21	6.87	0.00	1.14	0.38	1.14
tenocyte, donor3	11768-123I4	82.29	52.26	23.72	8.90	2.59	0.37	0.37	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	49.46	7.82	10.20	5.10	2.55	0.00	0.17	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	42.54	9.56	17.26	5.86	2.93	0.00	0.15	0.46
teratocarcinoma cell line:PA-1	10807-111A6	48.66	11.16	12.24	3.25	2.17	0.31	0.62	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	192.33	14.60	35.42	42.65	14.22	0.25	0.63	0.38
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	48.41	4.92	10.97	3.78	0.76	0.38	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	131.97	9.05	20.07	21.05	7.20	0.11	0.00	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	63.84	4.56	11.07	7.17	0.65	0.98	0.00	0.65
testis, adult, pool1	10026-101D8	93.09	22.33	25.66	4.62	0.64	0.21	0.11	0.32
testis, adult, pool2	10096-102C6	110.52	15.79	42.85	6.77	3.16	1.35	0.45	0.45
thalamus - adult, donor10196	10168-103B6	147.93	47.47	33.12	15.46	1.10	4.42	6.62	0.00
thalamus, adult, donor10252	10154-103A1	108.77	29.54	19.69	9.85	0.78	0.47	1.09	0.63
thalamus, adult, donor10258, tech_rep1	10370-105G1	78.52	53.89	10.78	3.08	0.00	1.54	6.16	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	67.69	28.16	13.67	7.41	1.65	0.82	6.59	0.66
thalamus, newborn, donor10223	10366-105F6	96.65	38.55	16.11	13.23	6.33	0.58	2.88	0.00
throat, adult	10209-103G2	87.88	37.95	19.47	9.49	1.25	0.50	0.00	0.50
throat, fetal, donor1	10061-101H7	98.42	50.89	19.20	8.23	1.52	1.83	1.83	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	78.10	39.75	11.92	4.97	0.99	0.40	0.00	0.20
thymus, adult, pool1	10027-101D9	67.20	7.65	19.58	7.26	2.88	0.10	0.00	0.00
thymus, fetal, pool1	10043-101F7	82.08	10.60	19.53	13.40	5.20	0.10	0.10	0.10
thyroid carcinoma cell line:KHM-5M	10776-110G2	145.19	32.04	28.85	15.29	3.99	0.53	0.13	1.06
thyroid carcinoma cell line:TCO-1	10783-110G9	80.74	16.34	22.91	5.87	0.98	0.14	0.42	0.28
thyroid, adult, pool1	10028-101E1	107.96	58.60	34.06	4.85	1.03	0.00	0.00	0.09
thyroid, fetal, donor1	10060-101H6	87.01	57.21	22.68	5.01	1.05	0.53	2.11	0.79
tongue epidermis (fungiform papillae), donor1	10288-104F9	101.63	30.80	18.48	3.08	0.00	0.00	3.08	0.00
tongue, adult	10203-103F5	92.10	43.49	23.03	7.91	1.16	0.23	0.00	0.23
tongue, fetal, donor1	10059-101H5	105.62	38.23	22.07	9.46	1.18	0.79	0.79	0.39
tonsil, adult, pool1	10047-101G2	106.59	27.65	27.45	12.52	1.90	0.00	0.10	0.20
trachea, adult, pool1	10029-101E2	94.72	35.09	22.74	9.49	0.90	0.16	0.08	0.08
trachea, fetal, donor1	10058-101H4	130.03	43.86	20.39	10.00	1.92	0.77	0.77	0.77
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	72.63	29.76	21.61	4.96	2.83	0.35	1.77	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	103.75	10.94	22.09	8.21	2.03	0.10	0.10	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	51.55	24.60	14.73	1.57	0.16	0.16	0.63	0.00
tridermal teratoma cell line:HGRT	10694-109G1	100.83	34.25	34.25	22.83	5.71	0.00	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	48.93	24.29	11.68	2.96	0.93	0.08	0.25	0.25
umbilical cord, fetal, donor1	10057-101H3	83.46	54.25	12.52	4.17	0.00	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	89.41	46.75	24.91	9.21	0.68	0.34	0.00	0.17
uterus, fetal, donor1	10055-101H1	108.53	55.29	16.89	22.52	4.10	1.02	1.02	0.00
vagina, adult	10204-103F6	54.93	10.99	15.51	11.63	1.94	0.00	0.00	0.00
vein, adult	10191-103E2	64.23	22.58	17.54	7.01	2.63	0.00	0.00	0.22
xeroderma pigentosum b cell line:XPL 17	10563-108A5	30.44	11.22	9.61	2.14	0.53	0.53	0.00	0.00